ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
CCI165_S85_contig_74_1 # 3 # 287 # -1 # ID=1_1;partial=10;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.470	CCI165_S85_contig_74_1	3	287	-	Strict	75	82.4185	qacJ	46.91	3007014	protein homolog model	n/a	n/a	disinfecting agents and antiseptics	antibiotic efflux	small multidrug resistance (SMR) antibiotic efflux pump	ATGAAAGGCTGGCTTTTTCTTGTTATCGCAATAGTTGGCGAAGTAATCGCAACATCCGCATTAAAATCTAGCGAGGGCTTTACTAAGCTTGCCCCTTCCGCCGTTGTCATAATCGGTTATGGCATCGCATTTTATTTTCTTTCTCTGGTTCTGAAATCCATCCCTGTCGGTGTTGCTTATGCAGTCTGGTCGGGACTCGGCGTCGTCATAATTACAGCCATTGCCTGGTTGCTTCATGGGCAAAAGCTTGATGCGTGGGGCTTTGTAGGTATGGGGCTCATAATT	MKGWLFLVIAIVGEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVLKSIPVGVAYAVWSGLGVVIITAIAWLLHGQKLDAWGFVGMGLII	MPYLYLVIAIITEIIGTSFLKTAEGFTKLWPTLGTLISFGICFYFLSVTMKYLPLNVSYATWAGLGLVLTTIVSVVIFKESVNLISIFSIILIIIGVVLLNVFGSSH	88.79	gnl|BL_ORD_ID|4652|hsp_num:0	5730			6	249	benzalkonium chloride
CCI165_S85_contig_74_2 # 451 # 1242 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=11-12bp;gc_cont=0.532	CCI165_S85_contig_74_2	451	1242	-	Strict	450	525.398	aadA	99.62	3002601	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(3'')	ATGAGGGAAGCGGTGATCGCCGAAGTATCGACTCAACTATCAGAGGTAGTTGGCGTCATCGAGCGCCATCTCGAACCGACGTTGCTGGCCGTACATTTGTACGGCTCCGCAGTGGATGGCGGCCTGAAGCCACACAGTGATATTGATTTGCTGGTTACGGTGACCGTAAGGCTTGATGAAACAACGCGGCGAGCTTTGATCAACGACCTTTTGGAAACTTCGGCTTCCCCTGGAGAGAGCGAGATTCTCCGCGCTGTAGAAGTCACCATTGTTGTGCACGACGACATCATTCCGTGGCGTTATCCAGCTAAGCGCGAACTGCAATTTGGAGAATGGCAGCGCAATGACATTCTTGCAGGTATCTTCGAGCCAGCCACGATCGACATTGATCTGGCTATCTTGCTGACAAAAGCAAGAGAACATAGCGTTGCCTTGGTAGGTCCAGCGGCGGAGGAACTCTTTGATCCGGTTCCTGAACAGGATCTATTTGAGGCGCTAAATGAAACCTTAACGCTATGGAACTCGCCGCCCGACTGGGCTGGCGATGAGCGAAATGTAGTGCTTACGTTGTCCCGCATTTGGTACAGCGCAGTAACCGGCAGAATCGCGCCGAAGGATGTCGCTGCCGACTGGGCAATGGAGCGCCTGCCGGCCCAGTATCAGCCCGTCATACTTGAAGCTAGACAGGCTTATCTTGGACAAGAAGAAGATCGCTTGGCCTCGCGCGCAGATCAGTTGGAAGAATTTGTTCACTACGTGAAAGGCGAGATCACCAAGGTAGTCGGCAAATAA	MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDETTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDERNVVLTLSRIWYSAVTGRIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLASRADQLEEFVHYVKGEITKVVGK	MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDETTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLASRADQLEEFVHYVKGEITKVVGK	100.00	gnl|BL_ORD_ID|590|hsp_num:0	650			0	789	spectinomycin; streptomycin
CCI165_S85_contig_74_3 # 1335 # 1808 # -1 # ID=1_3;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.397	CCI165_S85_contig_74_3	1335	1808	-	Perfect	300	322.783	dfrA1	100.0	3002854	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	GTGAAACTATCACTAATGGTAGCTATATCGAAGAATGGAGTTATCGGGAATGGCCCTGATATTCCATGGAGTGCCAAAGGTGAACAGCTCCTGTTTAAAGCTATTACCTATAACCAATGGCTGTTGGTTGGACGCAAGACTTTTGAATCAATGGGAGCATTACCCAACCGAAAGTATGCGGTCGTAACACGTTCAAGTTTTACATCTGACAATGAGAACGTAGTGATCTTTCCATCAATTAAAGATGCTTTAACCAACCTAAAGAAAATAACGGATCATGTCATTGTTTCAGGTGGTGGGGAGATATACAAAAGCCTGATCGATCAAGTAGATACACTACATATATCTACAATAGACATCGAGCCGGAAGGTGATGTTTACTTTCCTGAAATCCCCAGCAATTTTAGGCCAGTTTTTACCCAAGACTTCGCCTCTAACATAAATTATAGTTACCAAATCTGGCAAAAGGGTTAA	MKLSLMVAISKNGVIGNGPDIPWSAKGEQLLFKAITYNQWLLVGRKTFESMGALPNRKYAVVTRSSFTSDNENVVIFPSIKDALTNLKKITDHVIVSGGGEIYKSLIDQVDTLHISTIDIEPEGDVYFPEIPSNFRPVFTQDFASNINYSYQIWQKG	MKLSLMVAISKNGVIGNGPDIPWSAKGEQLLFKAITYNQWLLVGRKTFESMGALPNRKYAVVTRSSFTSDNENVVIFPSIKDALTNLKKITDHVIVSGGGEIYKSLIDQVDTLHISTIDIEPEGDVYFPEIPSNFRPVFTQDFASNINYSYQIWQKG	100.00	gnl|BL_ORD_ID|1835|hsp_num:0	1992			0	471	trimethoprim
CCI165_S85_contig_63_6 # 4351 # 5166 # -1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=AGxAG;rbs_spacer=5-10bp;gc_cont=0.609	CCI165_S85_contig_63_6	4351	5166	-	Perfect	500	528.865	sul2	100.0	3000412	protein homolog model	n/a	n/a	sulfonamide antibiotic	antibiotic target replacement	sulfonamide resistant sul	ATGAATAAATCGCTCATCATTTTCGGCATCGTCAACATAACCTCGGACAGTTTCTCCGATGGAGGCCGGTATCTGGCGCCAGACGCAGCCATTGCGCAGGCGCGTAAGCTGATGGCCGAGGGGGCAGATGTGATCGACCTCGGTCCGGCATCCAGCAATCCCGACGCCGCGCCTGTTTCGTCCGACACAGAAATCGCGCGTATCGCGCCGGTGCTGGACGCGCTCAAGGCAGATGGCATTCCCGTCTCGCTCGACAGTTATCAACCCGCGACGCAAGCCTATGCCTTGTCGCGTGGTGTGGCCTATCTCAATGATATTCGCGGTTTTCCAGACGCTGCGTTCTATCCGCAATTGGCGAAATCATCTGCCAAACTCGTCGTTATGCATTCGGTGCAAGACGGGCAGGCAGATCGGCGCGAGGCACCCGCTGGCGACATCATGGATCACATTGCGGCGTTCTTTGACGCGCGCATCGCGGCGCTGACGGGTGCCGGTATCAAACGCAACCGCCTTGTCCTTGATCCCGGCATGGGGTTTTTTCTGGGGGCTGCTCCCGAAACCTCGCTCTCGGTGCTGGCGCGGTTCGATGAATTGCGGCTGCGCTTCGATTTGCCGGTGCTTCTGTCTGTTTCGCGCAAATCCTTTCTGCGCGCGCTCACAGGCCGTGGTCCGGGGGATGTCGGGGCCGCGACACTCGCTGCAGAGCTTGCCGCCGCCGCAGGTGGAGCTGACTTCATCCGCACACACGAGCCGCGCCCCTTGCGCGACGGGCTGGCGGTATTGGCGGCGCTGAAAGAAACCGCAAGAATTCGTTAA	MNKSLIIFGIVNITSDSFSDGGRYLAPDAAIAQARKLMAEGADVIDLGPASSNPDAAPVSSDTEIARIAPVLDALKADGIPVSLDSYQPATQAYALSRGVAYLNDIRGFPDAAFYPQLAKSSAKLVVMHSVQDGQADRREAPAGDIMDHIAAFFDARIAALTGAGIKRNRLVLDPGMGFFLGAAPETSLSVLARFDELRLRFDLPVLLSVSRKSFLRALTGRGPGDVGAATLAAELAAAAGGADFIRTHEPRPLRDGLAVLAALKETARIR	MNKSLIIFGIVNITSDSFSDGGRYLAPDAAIAQARKLMAEGADVIDLGPASSNPDAAPVSSDTEIARIAPVLDALKADGIPVSLDSYQPATQAYALSRGVAYLNDIRGFPDAAFYPQLAKSSAKLVVMHSVQDGQADRREAPAGDIMDHIAAFFDARIAALTGAGIKRNRLVLDPGMGFFLGAAPETSLSVLARFDELRLRFDLPVLLSVSRKSFLRALTGRGPGDVGAATLAAELAAAAGGADFIRTHEPRPLRDGLAVLAALKETARIR	100.00	gnl|BL_ORD_ID|872|hsp_num:0	952			0	813	sulfadiazine; sulfadimidine; sulfadoxine; sulfamethoxazole; sulfisoxazole; sulfacetamide; mafenide; sulfasalazine; sulfamethizole
CCI165_S85_contig_59_4 # 2438 # 3274 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.559	CCI165_S85_contig_59_4	2438	3274	-	Strict	500	568.155	APH(6)-Id	99.64	3002660	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(6)	ATGTTCATGCCGCCTGTTTTTCCTGCTCATTGGCACGTTTCGCAACCTGTTCTCATTGCGGACACCTTTTCCAGCCTCGTTTGGAAAGTTTCATTGCCAGACGGGACTCCTGCAATCGTCAAGGGATTGAAACCTATAGAAGACATTGCTGATGAACTGCGCGGGGCCGACTATCTGGTATGGCGCAATGGGAGGGGAGCAGTCCGGTTGCTCGGTCGTGAGAACAATCTGATGTTGCTCGAATATGCCGGGGAGCGAATGCTCTCTCACATCGTTGCCGAGCACGGCGACTACCAGGCGACCGAAATTGCAGCGGAACTAATGGCGAAGCTGTATGCCGCATCTGAGGAACCCCTGCCTTCTGCCCTTCTCCCGATCCGGGATCGCTTTGCAGCTTTGTTTCAGCGGGCGCGCGATGATCAAAACGCAGGTTGTCAAACTGACTACGTCCACGCGGCGATTATAGCCGATCAAATGATGAGCAATGCCTCGGAACTGCGTGGGCTACATGGCGATCTGCATCATGAAAACATCATGTTCTCCAGTCGCGGCTGGCTGGTGATAGATCCCGTCGGTCTGGTCGGTGAAGTGGGCTTTGGCGCCGCCAATATGTTCTACGATCCGGCTGACAGAGACGACCTTTGTCTCGATCCTAGACGCATTGCACAGATGGCGGACGCATTCTCTCGTGCGCTGGACGTCGATCCGCGTCGCCTGCTCGACCAGGCGTACGCTTATGGGTGCCTTTCCGCAGCTTGGAACGCGGATGGAGAAGAGGAGCAACGCGATCTAGCTATCGCGGCCGCGATCAAGCAGGTGCGACAGACGTCATACTAG	MFMPPVFPAHWHVSQPVLIADTFSSLVWKVSLPDGTPAIVKGLKPIEDIADELRGADYLVWRNGRGAVRLLGRENNLMLLEYAGERMLSHIVAEHGDYQATEIAAELMAKLYAASEEPLPSALLPIRDRFAALFQRARDDQNAGCQTDYVHAAIIADQMMSNASELRGLHGDLHHENIMFSSRGWLVIDPVGLVGEVGFGAANMFYDPADRDDLCLDPRRIAQMADAFSRALDVDPRRLLDQAYAYGCLSAAWNADGEEEQRDLAIAAAIKQVRQTSY	MFMPPVFPAHWHVSQPVLIADTFSSLVWKVSLPDGTPAIVKGLKPIEDIADELRGADYLVWRNGRGAVRLLGRENNLMLLEYAGERMLSHIVAEHGDYQATEIAAELMAKLYAASEEPLPSALLPIRDRFAALFQRARDDQNAGCQTDYVHAAIIADQMMSNASELRGLHGDLHHENIMFSSRGWLVIDPVGLVGEVGFGAANMFYDPADRDDLCLDPRRIAQMADAFSRALDVDPRRLLDQAYAYGCLSAAWNADGEQEQRDLAIAAAIKQVRQTSY	100.00	gnl|BL_ORD_ID|948|hsp_num:0	1031			0	834	streptomycin
CCI165_S85_contig_59_5 # 3274 # 4077 # -1 # ID=1_5;partial=00;start_type=TTG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.562	CCI165_S85_contig_59_5	3274	4077	-	Strict	500	541.191	APH(3'')-Ib	99.63	3002639	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3'')	TTGAATCGAACTAATATTTTTTTTGGTGAATCGCATTCTGACTGGTTGCCTGTCAGAGGCGGAGAATCTGGTGATTTTGTTTTTCGACGTGGTGACGGGCATGCCTTCGCGAAAATCGCACCTGCTTCCCGCCGCGGTGAGCTCGCTGGAGAGCGTGACCGCCTCATTTGGCTCAAAGGTCGAGGTGTGGCTTGCCCCGAGGTGATCAACTGGCAGGAGGAACAGGAGGGTGCATGCTTGGTGATAACGGCAATTCCGGGAGTACCGGCGGCTGATCTGTCTGGAGCGGATTTGCTCAAAGCGTGGCCGTCAATGGGGCAGCAACTTGGCGCTGTTCACAGCCTATCGGTTGATCAATGTCCGTTTGAGCGCAGGCTGTCGCGAATGTTCGGACGCGCCGTTGATGTGGTGTCCCGCAATGCCGTCAATCCCGACTTCTTACCGGACGAGGACAAGAGTACGCCGCAGCTCGATCTTTTGGCTCGTGTCGAACGAGAGCTACCGGTGCGGCTCGACCAAGAGCGCACCGATATGGTTGTTTGCCATGGTGATCCCTGCATGCCGAACTTCATGGTGGACCCTAAAACTCTTCAATGCACGGGTCTGATCGACCTTGGGCGGCTCGGAACAGCAGATCGCTATGCCGATTTGGCACTCATGATTGCTAACGCCGAAGAGAACTGGGCAGCGCCAGATGAAGCAGAGCGCGCCTTCGCTGTCCTATTCAATGTATTGGGGATCGAAGCCCCCGACCGCGAACGCCTTGCCTTCTATCTGCGATTGGACCCTCTGACTTGGGGTTGA	MNRTNIFFGESHSDWLPVRGGESGDFVFRRGDGHAFAKIAPASRRGELAGERDRLIWLKGRGVACPEVINWQEEQEGACLVITAIPGVPAADLSGADLLKAWPSMGQQLGAVHSLSVDQCPFERRLSRMFGRAVDVVSRNAVNPDFLPDEDKSTPQLDLLARVERELPVRLDQERTDMVVCHGDPCMPNFMVDPKTLQCTGLIDLGRLGTADRYADLALMIANAEENWAAPDEAERAFAVLFNVLGIEAPDRERLAFYLRLDPLTWG	MNRTNIFFGESHSDWLPVRGGESGDFVFRRGDGHAFAKIAPASRRGELAGERDRLIWLKGRGVACPEVINWQEEQEGACLVITAIPGVPAADLSGADLLKAWPSMGQQLGAVHSLLVDQCPFERRLSRMFGRAVDVVSRNAVNPDFLPDEDKSTPQLDLLARVERELPVRLDQERTDMVVCHGDPCMPNFMVDPKTLQCTGLIDLGRLGTADRYADLALMIANAEENWAAPDEAERAFAVLFNVLGIEAPDRERLAFYLRLDPLTWG	100.00	gnl|BL_ORD_ID|1687|hsp_num:0	1830			0	801	streptomycin
CCI165_S85_contig_35_9 # 6858 # 7982 # -1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.532	CCI165_S85_contig_35_9	6858	7982	-	Strict	700	727.243	Klebsiella pneumoniae OmpK37	95.72	3004122	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; cephamycin; penam; penem	reduced permeability to antibiotic	General Bacterial Porin with reduced permeability to beta-lactams	ATGAAAAGAAAAGTACTGGCCCTCGTTATTCCGGCTTTATTAGCCGCTGGCGCCGCGCATGCGGCGGAAATTTATGATAAAGACGGAAATAAATTAGATGTCTATGGCAAGGTAGACGGTCTGCACTATTTCTCCAGCGACTCGAAAAAAGACGGCGACCAAACTTACGTTCGCTTTGGCTTTAAAGGCGAAACCCAGATCAACGATATGCTCACCGGTTACGGCCAGTGGGAATACAACGTTCAGGCCAACAATACCGAAAGCGCCGGCGATCAGGCGTGGACCCGTCTGGCCTTCGCCGGTATCAAAGTGGGCGATTACGGTTCCTTCGACTACGGTCGTAACTACGGCGTGCTGTACGACGTCGAAGGCTGGACCGATATGCTGCCGGAGTTCGGCGGCGACTCTTACACCTATGCGGATAACTTTATGGCAGGCCGCGCCAACGGCGTCGCGACCTACCGTAACAGCGACTTCTTCGGTCTGGTAGACGGTCTGAACTTCGCCCTGCAGTATCAGGGTAAAAACGAAGGCCAGAACGCCCAGGACATCAACGTCGGCACCAACAACCGCAGCAGCGACAGCGATGTTCGCTTTGACAACGGCGACGGTTTCGGTCTCTCTACCTCCTATAACTTCGGCATGGGCATCAGCGCGGCAGCGGCCTACACCTCATCTGACCGTACCAACGACCAGATGACCCAGACCAACGCCCGTGGCGATAAAGCTGAAGCCTGGACCGCTGGCCTGAAGTACGACGCCAACAATATCTACCTGGCGACCATGTACTCTGAAACCCGCAACATGACCCCTTACGGCAACGACGGCGTGGCCAACAAAACGCAAAACTTCGAAGTCACCGCTCAGTATCAGTTCGACTTTGGTCTGCGTCCGGCTATCTCCTATCTGCAGTCCAAAGGCAAAGATCTCTATAACACCGGCAGCTACGCCGATAAAGATCTGGTCAAATATATGGACGTCGGCGCCACCTATTACTTCAACCGTAATATGTCCACCTACGTTGATTACAAAATCAATCTGCTGGATGACAACGACAGCTTCTACAAAGACAACGGTATCTCTACCGACAACATCGTCGCGTTGGGCCTGGTTTACCAGTTCTGA	MKRKVLALVIPALLAAGAAHAAEIYDKDGNKLDVYGKVDGLHYFSSDSKKDGDQTYVRFGFKGETQINDMLTGYGQWEYNVQANNTESAGDQAWTRLAFAGIKVGDYGSFDYGRNYGVLYDVEGWTDMLPEFGGDSYTYADNFMAGRANGVATYRNSDFFGLVDGLNFALQYQGKNEGQNAQDINVGTNNRSSDSDVRFDNGDGFGLSTSYNFGMGISAAAAYTSSDRTNDQMTQTNARGDKAEAWTAGLKYDANNIYLATMYSETRNMTPYGNDGVANKTQNFEVTAQYQFDFGLRPAISYLQSKGKDLYNTGSYADKDLVKYMDVGATYYFNRNMSTYVDYKINLLDDNDSFYKDNGISTDNIVALGLVYQF	MKRKVLALVIPALLAAGAAHAAEIYNKDGNKLDLYGKVDGLHYFSSDSKKDGDQTYLRFGFKGETQINDILTGYGQWEYNVQANNTETSSDQAWTRLAFAGIKVGDYGSFDYGRNYGVLYDVEGWTDILPEFGGDSYTYADNFMAGRANGVATYRNSDFFGLVEGLNFALQYQGKNEGQNAQDINVGTNNRSSDSDVRFDNGDGFGLSTSYDFGMGISAAAAYTSSDRTNDQMTQTNARGDKAEAWTAGLKYDANDIYLATMYSETRNMTPYGNDGVANKTQNFEVTAQYQFDFGLRPAISYLQSKGKDLYNNGRYADKDLVKYMDVGATYYFNRNMSTYVDYKINLLDGNDKFYEDNGISTDNIVALGLVYQF	100.00	gnl|BL_ORD_ID|2632|hsp_num:0	2785			0	1122	cefoxitin; cefotaxime
CCI165_S85_contig_13_127 # 127705 # 128124 # -1 # ID=1_127;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.640	CCI165_S85_contig_13_127	127705	128124	-	Strict	280	281.182	FosA6	97.12	3004111	protein homolog model	n/a	n/a	phosphonic acid antibiotic	antibiotic inactivation	fosfomycin thiol transferase	ATGCTGAGCGGACTGAATCACCTGACCCTGGCGGTCAGCCAGCTGGCGCCGAGCGTGGCGTTTTATCAGCAGCTGTTGGGCATGACGCTGCACGCCCGCTGGGACAGCGGCGCCTATCTCTCCTGCGGCGATCTGTGGCTGTGCCTGTCGCTGGATCCGCAGCGGCGTGTCACTCCGCCGGAGGAGAGCGACTACACCCATTATGCGTTTAGCATTAGCGAAGCGGATTTCGCCCGCTTCGCCGCTCGCCTTGAGGTTGCCGGCGTGGCGGTGTGGAAGTTGAACCGTAGCGAAGGCGCCTCGCACTATTTCCTCGACCCCGACGGCCACAAGCTGGAGCTGCACGTCGGCAGTCTCGCCCAGCGCCTGGCCGCCTGCCGCGAGCAGCCGTATAAGGGGATGGTGTTTTTTGACCAGTGA	MLSGLNHLTLAVSQLAPSVAFYQQLLGMTLHARWDSGAYLSCGDLWLCLSLDPQRRVTPPEESDYTHYAFSISEADFARFAARLEVAGVAVWKLNRSEGASHYFLDPDGHKLELHVGSLAQRLAACREQPYKGMVFFDQ	MLSGLNHLTLAVSQLAPSVAFYQQLLGMTLHARWDSGAYLSCGDLWLCLSLDPQRRVTPPEESDYTHYAFSISEADFASFAARLEAAGVAIWKLNRSEGASHYFLDPDGHKLELHVGSLAQRLAACREQQYKGMVFFDQ	100.00	gnl|BL_ORD_ID|2399|hsp_num:0	2779			0	417	fosfomycin
CCI165_S85_contig_15_91 # 104600 # 107713 # -1 # ID=1_91;partial=00;start_type=ATG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.602	CCI165_S85_contig_15_91	104600	107713	-	Strict	1900	1948.33	acrD	90.84	3000491	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGCGAATTTCTTTATCGATCGCCCCATTTTTGCGTGGGTGCTGGCAATCCTGTTATGCCTGACGGGCACCCTTGCCATTTTGTCGCTGCCAGTTGAACAGTATCCCGATCTGGCCCCGCCGAATGTACGGGTTACAGCCAACTATCCTGGCGCCTCCGCACAAACCCTGGAGAATACCGTCACCCAGGTTATCGAACAGAATATGACCGGCCTCGATAACCTGATGTATATGTCATCCCAGAGCAGCGCCACCGGCCAGGCGACCATCACCCTCAGTTTTACCGCCGGTACCGACCCGGACGAAGCGGTACAGCAGGTGCAAAACCAGCTGCAGTCGGCGATGCGTAAACTGCCGCAGGCGGTGCAAAACCAGGGGGTTACGGTACGCAAGACCGGCGATACCAATATCCTGACCCTCGCCTTCGTCTCCACCGACGGCAGTATGGATAAACAGGATATCGCCGACTACGTCGCCAGTAACATTCAGGACCCGCTCAGTCGCGTCAACGGCGTGGGGGATATCGACGCCTACGGCTCGCAATACTCAATGCGCATCTGGCTCGATCCGGCAAAGCTCAATAGCTTCCAGCTGACCACCAAGGATGTTACCGACGCTATTAGTTCGCAGAACGCCCAGATTGCCGTCGGCCAGCTCGGCGGCACGCCTTCCGTGGATAAGCAGGCGCTGAACGCCACCATCAACGCGCAATCTCTGCTGCAAACCCCGGAACAGTTCCGCAATATCACCCTGCGCGTCAATCAGGATGGCTCAGAGGTGACCCTCGGCGATGTCGCTACCGTGGAGATGGGGGCGGAGAAGTATGACTATCTTAGCCGCTACAATCGCCAGGCCGCCTCTGGCCTGGGAATTAAGCTCGCCTCCGGCGCCAACGAAATGGCCACCGCGGAGCGCGTGATCGCTCGCCTCAATGAGCTCTCGCAGTATTTCCCGCACGGGCTGGAATATAAAGTCGCCTACGAGACCACCTCCTTCGTGAAGGCTTCTATTACCGACGTGGTGAAAACCCTGCTGGAGGCGATCCTGCTGGTTTTCCTCGTGATGTATCTTTTCCTGCAGAACTTCCGCGCCACTCTGATCCCGACCATCGCCGTACCGGTGGTGCTGATGGGCACCTTCGCGGTGCTCTATGCCTGTGGTTACAGCATCAACACCCTGACGATGTTCGCGATGGTGCTGGCGATCGGCCTGCTGGTGGATGACGCCATCGTGGTGGTGGAGAACGTTGAGCGCATCATGAGCGAGGAAGGACTGTCGCCGCGGGAAGCCACCCGCAAATCGATGGGACAAATTCAGGGCGCGCTGGTGGGGATCGCGATGGTGCTGTCGGCGGTGTTTGTGCCGATGGCCTTCTTCGGCGGCACCACCGGCGCTATCTATCGCCAGTTCTCTATTACGATTGTCGCGGCGATGGTCCTCTCGGTGCTGGTGGCCATGATCCTCACCCCGGCCCTTTGCGCTACCCTGCTCAAGCCGATTAAACCAGGTGAATCCCATGAGCGAAAAGGCTTCTTCGGCTGGTTCAACCGCACCTTTAACCGCAGCGCCAGCCGCTATGAAACTTTCGTCGGCAAGATCCTTCACCGCTCGCTGCGCTGGATGCTGTTCTACATCGTCCTGCTCGGCGGGATGGTGTTCTTGTTCCTGCATCTGCCCACTTCGTTCCTGCCGCTGGAGGATCGGGGGATGTTCACCACCTCGGTACAGTTGCCGAGCGGCAGCACCCAACAGCAGACGCTGAAAGTGGTACAGAAAGCGGAAGATTACTTCCTCAATAACGAGAAGCAGAACGTCGAGTCAGTGTTTGCTACCGTTGGCTCCGGCCCCGGCGGCAACGGGCAGAACGTAGCCCGCATGTTTGTGCGCCTCAAAGACTGGGACCAGCGCGATCCGCAAACCGGCTCCTCCTTTGCCATTATTGAACGCGCCACCAAAGCGTTTAATCAGATCAACGAAGCCCGGGTCATCGCCAGCAGCCCGCCGGCAATCAGCGGCCTCGGCAGTTCGGCAGGCTTCGACATGGAGCTGGAAGATCACGCCGGTAAGGGGCACGATGCGCTGATGGCGGCGCGCGATACGCTGCTTGAGCTGGCGGCTAAAAACCCGCTGTTGACCCGCGTCCGGCATAACGGGCTCGACGACAGCCCGCAGCTGCAGGTCGATATCGATCAGCGTAAAGCTCAGGCGCTGGGCGTCTCCATTGATGACATCAACGATACGCTGCAAACCGCCTGGGGGTCGAGCTACGTCAACGACTTTATGGATCGCGGGAGGGTGAAGAAAGTCTACGTCCAGGCGGCGGCGAAATATCGGATGCTGCCTGACGATATCAATCTCTGGTACGTCCGCAACAGCAGCGGCACGATGGTGCCGTTCTCGGCCTTCGCCACCTCGCACTGGGAGACCGGTTCGCCGCGCCTGGAGCGCTACAATGGCTACTCGGCGGTGGAGATCGTCGGTGAAGCGGCGCCGGGCATCAGTACCGGTACCGCGATGGACATGATGGAGAAGCTGGCCGCGCAGCTGCCGACCGGCTTTGGCCTCGAATGGACCGCCATGTCCTATCAGGAACGCCTCTCCGGCGCTCAGGCGCCGGCCCTGTACGCGATTTCCCTGCTGGTGGTGTTCCTGTGCCTGGCGGCGCTGTACGAGAGCTGGTCGGTGCCGTTCTCGGTGATGCTGGTGGTTCCGCTCGGGGTGATTGGCGCTCTGCTGGCGACCTGGATGCGCGGCCTGGAGAATGACGTTTATTTTCAGGTGGGCCTGTTGACGGTGATCGGCCTGTCGGCGAAAAACGCCATTCTGATCGTCGAGTTCGCCAATGAGCTTAACGAGAAAGGCCAGGATCTGCTCAGCGCCACGCTGTCGGCCTGCCGTCAGCGCCTGCGCCCTATCCTGATGACCTCGCTGGCGTTTATCTTCGGCGTGCTGCCGATGGCCACCAGCACCGGCGCCGGTTCCGGCAGCCAGCATGCGGTCGGCACCGGGGTGATGGGCGGGATGATCTCCGCCACCGTGCTGGCCATCTTTTTCGTACCGCTGTTCTTTGTGCTGGTGCGTCGCCGCTTTCCGCTGAAGGAGCGTCCGCAATAA	MANFFIDRPIFAWVLAILLCLTGTLAILSLPVEQYPDLAPPNVRVTANYPGASAQTLENTVTQVIEQNMTGLDNLMYMSSQSSATGQATITLSFTAGTDPDEAVQQVQNQLQSAMRKLPQAVQNQGVTVRKTGDTNILTLAFVSTDGSMDKQDIADYVASNIQDPLSRVNGVGDIDAYGSQYSMRIWLDPAKLNSFQLTTKDVTDAISSQNAQIAVGQLGGTPSVDKQALNATINAQSLLQTPEQFRNITLRVNQDGSEVTLGDVATVEMGAEKYDYLSRYNRQAASGLGIKLASGANEMATAERVIARLNELSQYFPHGLEYKVAYETTSFVKASITDVVKTLLEAILLVFLVMYLFLQNFRATLIPTIAVPVVLMGTFAVLYACGYSINTLTMFAMVLAIGLLVDDAIVVVENVERIMSEEGLSPREATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGTTGAIYRQFSITIVAAMVLSVLVAMILTPALCATLLKPIKPGESHERKGFFGWFNRTFNRSASRYETFVGKILHRSLRWMLFYIVLLGGMVFLFLHLPTSFLPLEDRGMFTTSVQLPSGSTQQQTLKVVQKAEDYFLNNEKQNVESVFATVGSGPGGNGQNVARMFVRLKDWDQRDPQTGSSFAIIERATKAFNQINEARVIASSPPAISGLGSSAGFDMELEDHAGKGHDALMAARDTLLELAAKNPLLTRVRHNGLDDSPQLQVDIDQRKAQALGVSIDDINDTLQTAWGSSYVNDFMDRGRVKKVYVQAAAKYRMLPDDINLWYVRNSSGTMVPFSAFATSHWETGSPRLERYNGYSAVEIVGEAAPGISTGTAMDMMEKLAAQLPTGFGLEWTAMSYQERLSGAQAPALYAISLLVVFLCLAALYESWSVPFSVMLVVPLGVIGALLATWMRGLENDVYFQVGLLTVIGLSAKNAILIVEFANELNEKGQDLLSATLSACRQRLRPILMTSLAFIFGVLPMATSTGAGSGSQHAVGTGVMGGMISATVLAIFFVPLFFVLVRRRFPLKERPQ	MANFFIDRPIFAWVLAILLCLTGTLAIFSLPVEQYPDLAPPNVRVTANYPGASAQTLENTVTQVIEQNMTGLDNLMYMSSQSSGTGQASVTLSFKAGTDPDEAVQQVQNQLQSAMRKLPQAVQNQGVTVRKTGDTNILTIAFVSTDGSMDKQDIADYVASNIQDPLSRVNGVGDIDAYGSQYSMRIWLDPAKLNSFQMTAKDVTDAIESQNAQIAVGQLGGTPSVDKQALNATINAQSLLQTPEQFRDITLRVNQDGSEVRLGDVATVEMGAEKYDYLSRFNGKPASGLGVKLASGANEMATAELVLNRLDELAQYFPHGLEYKVAYETTSFVKASIEDVVKTLLEAIALVFLVMYLFLQNFRATLIPTIAVPVVLMGTFSVLYAFGYSVNTLTMFAMVLAIGLLVDDAIVVVENVERIMSEEGLTPREATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGTTGAIYRQFSITIVAAMVLSVLVAMILTPALCATLLKPLKKGEHHGQKGFFAWFNQMFNRNAERYEKGVAKILHRSLRWIVIYVLLLGGMVFLFLRLPTSFLPLEDRGMFTTSVQLPSGSTQQQTLKVVEQIEKYYFTHEKDNIMSVFATVGSGPGGNGQNVARMFIRLKDWSERDSKTGTSFAIIERATKAFNQIKEARVIASSPPAISGLGSSAGFDMELQDHAGAGHDALMAARNQLLALAAENPELTRVRHNGLDDSPQLQIDIDQRKAQALGVAIDDINDTLQTAWGSSYVNDFMDRGRVKKVYVQAAAPYRMLPDDINLWYVRNKDGGMVPFSAFATSRWETGSPRLERYNGYSAVEIVGEAAPGVSTGTAMDIMESLVKQLPNGFGLEWTAMSYQERLSGAQAPALYAISLLVVFLCLAALYESWSVPFSVMLVVPLGVIGALLATWMRGLENDVYFQVGLLTVIGLSAKNAILIVEFANEMNQKGHDLFEATLHACRQRLRPILMTSLAFIFGVLPMATSTGAGSGGQHAVGTGVMGGMISATILAIYFVPLFFVLVRRRFPLKPRPE	100.00	gnl|BL_ORD_ID|1305|hsp_num:0	1427			0	3111	neomycin; amikacin; kanamycin A; tobramycin; gentamicin
CCI165_S85_contig_16_20 # 15138 # 15770 # 1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.518	CCI165_S85_contig_16_20	15138	15770	+	Strict	400	432.95	CRP	99.05	3000518	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGTGCTTGGCAAACCGCAAACAGACCCTACCCTTGAATGGTTCTTGTCTCATTGCCACATTCATAAGTACCCATCAAAGAGCACGCTGATCCACCAGGGTGAGAAAGCAGAAACGCTGTACTACATCGTTAAAGGCTCCGTGGCTGTACTCATCAAGGATGAAGAAGGTAAAGAGATGATCCTCTCCTACCTCAACCAGGGCGATTTCATCGGTGAATTAGGCCTGTTTGAAGAGGGTCAGGAGCGTAGCGCCTGGGTACGGGCGAAAACCGCATGTGAAGTGGCCGAAATCTCTTATAAGAAATTCCGTCAGCTGATCCAGGTGAACCCGGACATTCTGATGCGTCTCTCTTCGCAAATGGCTCGCCGTCTGCAGGTGACGTCTGAGAAAGTGGGCAACCTCGCCTTCCTCGACGTGACGGGCCGTATCGCCCAGACGCTGCTGAACCTGGCGAAGCAACCCGATGCCATGACCCACCCGGACGGTATGCAAATTAAAATTACCCGTCAGGAAATTGGTCAGATCGTCGGCTGCTCTCGTGAAACCGTTGGCCGTATTTTGAAAATGCTGGAAGATCAGAACCTGATTTCCGCCCACGGTAAAACTATCGTCGTCTACGGTACCCGTTAA	MVLGKPQTDPTLEWFLSHCHIHKYPSKSTLIHQGEKAETLYYIVKGSVAVLIKDEEGKEMILSYLNQGDFIGELGLFEEGQERSAWVRAKTACEVAEISYKKFRQLIQVNPDILMRLSSQMARRLQVTSEKVGNLAFLDVTGRIAQTLLNLAKQPDAMTHPDGMQIKITRQEIGQIVGCSRETVGRILKMLEDQNLISAHGKTIVVYGTR	MVLGKPQTDPTLEWFLSHCHIHKYPSKSKLIHQGEKAETLYYIVKGSVAVLIKDEEGKEMILSYLNQGDFIGELGLFEEGQERSAWVRAKTACEVAEISYKKFRQLIQVNPDILMRLSAQMARRLQVTSEKVGNLAFLDVTGRIAQTLLNLAKQPDAMTHPDGMQIKITRQEIGQIVGCSRETVGRILKMLEDQNLISAHGKTIVVYGTR	100.00	gnl|BL_ORD_ID|801|hsp_num:0	869			0	630	erythromycin; cloxacillin; oxacillin; norfloxacin
CCI165_S85_contig_16_119 # 127290 # 128945 # -1 # ID=1_119;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.613	CCI165_S85_contig_16_119	127290	128945	-	Strict	400	1079.32	ArnT	97.28	3005053	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGAAAAGCATTCGCTATGGCGTCTCTCTGATTGCGCTGTTTGCGCTGTATTACCTGCTGCCGCTCAATTTCCGTTTGCTCTGGCAACCCGATGAAACACGCTATGCGGAGATCAGCCGTGAAATGCTGGCCACCGGCGACTGGGTGGTGCCGCATTTTCTCGGGCTGCGCTACTTCGAAAAGCCGATTGCCGGTTACTGGATCAACAGTGTCGGCCAGTGGCTGTTTGGCCATAATAACTTCGGCGTACGCTTCGGGTCGGTCTTCGCCATCACCATGACCGCCGTGCTGGTGGCCTGGCTGGCGTGGCGCATCTTTCGCGATAAGCGGGTAGCCGTCCTGTCGCCAGTGATTTTTCTCACCGCGATGCTGGTGTATGCGATTGGTACCTATGCGGTGCTGGACCCGATGATCACCCTGTGGCTGGCGCTGGCGATGTGCAGCTTCTGGGGCGCGACGCAGGCGCAGAGCCGCGGCGGCAAAATACTGGGTTACGTGCTGTTGGGCGTCGCCTGCGGTATGGGGGTGATGACCAAAGGTTTCCTTGCGCTGGCGGTGCCGGTGGTGGGCGTTCTGCCGTGGGTGATCGCCCGTAAACGCTGGCGTGAAGTGCTGACCTACGGTTGGCTGGCGGTGGTCGTCTGTACGCTGGTGGTGCTGCCCTGGGGGCTGGCTATCGCCCAGCGCGAGCCGGACTTCTGGCGCTATTTCTTCTGGGTCGAGCATATTCAGCGTTTCGCCGAAAAAGACGCCCAGCATAAAGCGCCATTCTGGTACTACATCCCATTCCTGATCGCCGGCAGCTTGCCGTGGCTGGCCCTGCTGCCAGGGGCGCTGAAGCGCGGCTGGCGTGAGCGCGATGAGGCCCGCGGCGCGCTGTATCTGCTCGGTTGGGTGGCGATGCCGTTCCTGTTCTTCAGTATTGCTAAAGGCAAACTGCCGACCTATATCCTGCCGTGCTTTGCGCCGCTGTCGATCCTGATGGCCCGCTACGCGCTGGAGGCGGCGAAGACCGGCGCGAAAGCGCTGCGCATCAATGGGATGATCAACCTGGGCTTTGGCCTGCTGGGGCTGATCGCCGTGCTGGTGGTCTCGCCCTGGGGCGTGATGCACAAGCCGGTATGGACCAAGATTGAGCTGTATAAATGTCTGCTGGCGGCCATCGCCTTCGCCGTCTGGGCGCTGATGGGCTGGTTGGCGATGAAAGACGCTGGTCGCCGTTGGAGCCTGGCGGCGCTTTGCCCGCTTGGCCTGGCGCTGCTGGTGGGCTTCGCCATTCCGGACCGGGTTATCGACAGCAAACAGCCGCAGTTCCTCGTGGACATCGTCAGCGAATCCCTGCAGCCCAGCCGTTACGTCCTGACGAACAACGTCGGGATCGCCGGCGGCCTGGCCTGGGAGCTGAAGCGAAGCGATATTATTATGTTCGACAAACAGGGTGAGCTGAAGTACGGTCTCGACTGGCCGGACGCTCAGGGAAGCTTTGTCAGCCAGGCCGGGTTTGCCGACTGGCTGGCCACGCATCGTCAGCAGGGGCCGGTCTCGCTGGTGCTGTTGATGGATAAAGGAGAGAGTATGGTCGACTTACCGTTACCGAAACCCGATAACGCCTATGAGCTGGGTCGGGTGGTCTTCCTTCAGTACCTGCCGCAATGA	MKSIRYGVSLIALFALYYLLPLNFRLLWQPDETRYAEISREMLATGDWVVPHFLGLRYFEKPIAGYWINSVGQWLFGHNNFGVRFGSVFAITMTAVLVAWLAWRIFRDKRVAVLSPVIFLTAMLVYAIGTYAVLDPMITLWLALAMCSFWGATQAQSRGGKILGYVLLGVACGMGVMTKGFLALAVPVVGVLPWVIARKRWREVLTYGWLAVVVCTLVVLPWGLAIAQREPDFWRYFFWVEHIQRFAEKDAQHKAPFWYYIPFLIAGSLPWLALLPGALKRGWRERDEARGALYLLGWVAMPFLFFSIAKGKLPTYILPCFAPLSILMARYALEAAKTGAKALRINGMINLGFGLLGLIAVLVVSPWGVMHKPVWTKIELYKCLLAAIAFAVWALMGWLAMKDAGRRWSLAALCPLGLALLVGFAIPDRVIDSKQPQFLVDIVSESLQPSRYVLTNNVGIAGGLAWELKRSDIIMFDKQGELKYGLDWPDAQGSFVSQAGFADWLATHRQQGPVSLVLLMDKGESMVDLPLPKPDNAYELGRVVFLQYLPQ	MKSIRYGVSLIALFALYYLLPLNFRLLWQPDETRYAEISREMLATGDWVVPHFLGLRYFEKPIAGYWINSIGQWLFGHNNFGVRFGSVFAITMTALLVAWLAWRIFRDKRVAILSLIIFLTAMLVYAIGTYAVLDPMITLWLALAMCSFWGAVQAHSRSGKILGYVLLGVACGMGVMTKGFLALAVPVVGVLPWVIARKRWREVLTYGWLAVIVCTLVVLPWGLAIAQREPDFWRYFFWVEHIQRFAEKDAQHKAPFWYYIPFLIAGSLPWLALLPGALKRGWLERDEARGALYLLGWVAMPFLFFSIAKGKLPTYILPCFAPLSILMARYALEAAKTGAKALRINGMINLGVGLLGLIAVLVVSPWGFMHKPVWTKIELYKCLLAAIAFAVWALMGWLAMKDSGRRWSLAALCPLGLALLVGFAIPDRVIDSKQPQFLVDIVSESLQPSRYVLTNNVGIAGGLAWELKRSDIIMFDKQGELKYGLDWPDAQGSFVSQAGFADWLAAHRQQGPVSLVLLMDKGESMLDLPLPKPDNAYELGRVVFLQYLPQ	100.00	gnl|BL_ORD_ID|2789|hsp_num:0	3795			0	1653	colistin A; colistin B
CCI165_S85_contig_16_122 # 131826 # 132809 # -1 # ID=1_122;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.590	CCI165_S85_contig_16_122	131826	132809	-	Strict	550	576.63	PmrF	83.38	3003578	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGCTTACTTACCCTCCCGTGAAGAAGGTCTCGGTGGTTATTCCGGTTTATAACGAACAGGATAGCCTGCCGGAGCTGCTTCGTCGTACGGATACCGCCTGCGCCACGCTGGGGCGGCAATATGAAATTCTGCTGATCGACGATGGCAGCAGCGACGATTCCGCGCGCATGCTCACCGAAGCTGCCGAGGCGGAAGGCAGTCACGTCGTCGCCGTGCTGTTAAACCGTAACTACGGGCAGCACTCGGCGATCATGGCCGGTTTCAGCCATGTAACCGGCGATTTAATCATTACGCTTGACGCCGACCTGCAAAACCCGCCGGAAGAGATCCCGCGGTTGGTAGAGAAGGCGGATGAAGGCTACGACGTGGTGGGCACCGTTCGCCAGAACCGTCAGGACAGCATCTTCCGCAAAACCGCGTCGAAGATGATCAACCGCCTGATCCAGCGCACCACCGGCAAAGCGATGGGCGACTACGGCTGCATGCTGCGCGCTTACCGCCGCCATATCATCGACGCCATGCTCAACTGCCATGAGCGCAGCACCTTTATCCCGATCCTGGCGAATACCTTCGCCCGGCGCGCGGTGGAGATCCCGGTGATGCACGCCGAGCGCGAATTCGGCGACTCCAAATACAGCTTTATGCGCCTGATCAACCTGATGTACGACCTGGTGACCTGTCTGACCACCACGCCGCTGCGTCTGCTCAGCATTTTCGGCAGCGTGATAGCCCTGCTGGGCTTCGCCTTTGGCCTGATGCTGGTGGTGCTGCGTCTGGCCTTTGGCCCGCAGTGGGCGGCGGAAGGGGTATTTATGCTCTTCGCCGTGCTGTTTATGTTCATCGGCGCTCAGTTTGTCGGGATGGGCCTGCTCGGGGAGTATATCGGCCGCATCTATAACGACGTGCGCGCGCGTCCCCGCTACTTTATTCAACGTGTTGTTCGCCAGCCGGAAACGGCATCTAAAGAGGAAGATCGTTCATGA	MLTYPPVKKVSVVIPVYNEQDSLPELLRRTDTACATLGRQYEILLIDDGSSDDSARMLTEAAEAEGSHVVAVLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVEKADEGYDVVGTVRQNRQDSIFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIIDAMLNCHERSTFIPILANTFARRAVEIPVMHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSIFGSVIALLGFAFGLMLVVLRLAFGPQWAAEGVFMLFAVLFMFIGAQFVGMGLLGEYIGRIYNDVRARPRYFIQRVVRQPETASKEEDRS	MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVEASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEGYDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHERSTFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLGSIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYTDVRARPRYFVQQVIRPSSKENE	101.55	gnl|BL_ORD_ID|1934|hsp_num:0	2014			0	966	polymyxin B
CCI165_S85_contig_19_29 # 37630 # 40752 # 1 # ID=1_29;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.644	CCI165_S85_contig_19_29	37630	40752	+	Strict	1800	1832.77	mdtB	90.19	3000793	protein homolog model	n/a	n/a	aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCAGGTGTTACCCCCAGGCCGCACCGGCGGCCCGTCCCGGCTGTTTATTATGCGTCCGGTGGCCACCACTCTGCTGATGGTGGCGATCCTGTTAGCCGGGATCATCGGCTACCGCTTTCTGCCGGTCTCCGCGTTACCGGAGGTGGATTACCCGACCATTCAGGTAGTCACCCTCTATCCGGGCGCCAGCCCGGACGTGGTGACCTCCGCCATCACCGCCCCGCTGGAACGCCAGTTCGGCCAGATGTCCGGGCTTAAGCAGATGTCATCGCAAAGTTCCGGCGGCGCCTCGGTCGTCACGCTCCAGTTCCAGCTGACCCTGCCGCTGGACGTTGCCGAGCAGGAAGTGCAGGCGGCCATCAACGCCGCCACCAACCTGCTGCCGAACGATCTGCCCAACCCGCCGGTCTACAGCAAGGTGAACCCGGCGGATCCGCCGATCATGACCCTCGCCGTTACCTCCTCCGCGATCCCGATGACCCAGGTAGAGGATATGGTGGAGACGCGGGTGGCGCAGAAGATCTCTCAGGTTTCCGGCGTCGGTCTGGTGACCCTCGCCGGCGGCCAGCGCCCGGCGGTGCGGGTGAAGCTTAACGCCCAGGCCATCGCCGCCCTCGGCCTGACCAGCGAAACCGTGCGCACCGCCATCACCAGCGCCAACGTTAACTCGGCGAAAGGCAGCCTCGATGGCCCGGCCCGCGCGGTAACGCTTTCCGCTAACGATCAGATGCAGTCCGCTGAGGATTACCGCCGCCTGATTATCGCTTATCAGAACGGGGCGCCGATCCGGCTCGGCGATGTCGCCAGCGTCGAACAAGGGGCCGAAAACAGCTGGCTGGGGGCGTGGGCCAACCAGCAGCGGGCGATCGTGATGAACGTCCAGCGCCAGCCGGGGGCCAACATTATCGACACCGCCGACAGCATTCGCCAGATGCTGCCGCAGCTTACCGAGAGCCTGCCGAAATCGGTGAAGGTGCAGGTTCTCTCCGACCGGACCACCAACATCCGCGCCTCGGTGCGCGACACCCAGTTTGAGCTGATGCTGGCCATCGCCCTGGTGGTGATGATCATCTACCTGTTCCTGCGCAACGTGCCAGCGACCATTATTCCCGGCGTCGCGGTGCCGCTGTCGCTGGTGGGCACCTTCGCGGTGATGGTGTTCCTCGACTTCTCGATCAACAACCTGACGCTGATGGCCCTGACCATCGCCACCGGCTTTGTGGTGGATGACGCCATCGTGGTGATCGAGAACATCTCGCGCTATATCGAGAAAGGCGAGAAGCCGCTGGCCGCTGCGCTGAAAGGCGCGGGAGAAATCGGCTTCACCATCATCTCCCTCACCTTCTCGCTGATCGCGGTGCTGATCCCGCTGCTGTTTATGGGCGATATCGTTGGCCGCCTGTTCCGCGAATTCGCCGTTACCCTTGCCGTCGCCATCCTGATCTCGGCGGTGGTCTCCCTGACCCTGACGCCGATGATGTGCGCCCGCATGTTAAGCCACGAATCGCTGCGTAAGCAGAACCGCTTCTCGCGGGCCAGCGAGCGCTTCTTCGACCGGGTGATCGCCGTCTATGGCCGCTGGCTGAGCCGGGTGCTGAACCATCCTTGGCTGACGCTCGGCGTCGCCCTGAGCACCCTGGCGCTGTCGATTCTGCTGTGGGTCTTTATCCCGAAAGGCTTTTTCCCGATCCAGGATAACGGCATTATCCAGGGCACCCTCCAGGCGCCGCAGTCGGTCTCCTTCGCCAGTATGGCCCAGCGCCAGCAGCAGGTTTCCGACATTATTCTCAAGGATCCGGCGGTGGAGAGCCTGACCTCGTTCGTCGGCGTCGACGGCACCAACCCGGCGCTGAACAGCGCCCGCCTGCAGATCAACCTCAAGCCGCTGGATGAACGCGACGACCGCGTCCAGACGGTGATTAGCCGTCTGCAGCAGGCGGTGGCCGGTGTCCCGGGCGTGGCGCTCTATCTGCAGCCGACCCAGGATCTGACCATCGACACCACGGTGAGCCGCACCCAGTACCAGTTCACTCTGCAGGCGAACTCCCTCGAGGCGTTGAGCACCTGGGTGCCGCCGCTGCTCAGTCGCCTGCAGGCCCAGCCGCAGCTGGCCGACGTCAGCAGCGACTGGCAGGACAAAGGCCTGGCCGCCTATATCAAGGTGGACAGGGACAGCGCCAGCCGCCTCGGCATCTCGATGGCCGATGTCGATAACGCGCTGTACAACGCCTTCGGCCAGCGGCTGATCTCCACCATTTACACCCAGGCGAATCAGTATCGCGTGGTGCTAGAGCAGGATACCGAGGCGACCCCGGGCCTGGCGGCGCTGGATAATATCCGCCTGACCAGCAGCGACGGCGGCATCGTGCCGCTGACCGCCATCGCCACGGTGGAGCAGCGCTTTACCCCGCTGTCGGTGAACCACCTCGATCAGTTCCCGGTGACCACCATCTCGTTTAACGTTCCGGACAACTACTCGCTGGGCGAAGCGGTAGAGGCTATCCTCACCGCCGAACAGTCGCTGGATTTCCCGAGCGATATTCGCACTCAGTTCCAGGGCAGCTCGCTGGCCTTCCAGTCGGCGCTGGGCAGCACCGTCTGGCTGGTCGTGGCCGCGGTGGTGGCGATGTATATCGTCCTGGGGGTGCTGTATGAGAGCTTTATCCATCCGATCACCATTCTCTCCACTCTGCCCACCGCGGGGGTCGGGGCGCTGCTGGCGCTGTGGCTGGCGGGCAGCGAGCTGGACGTGATCGCCATCATCGGCATCATTCTGCTGATCGGCATCGTGAAGAAGAACGCCATCATGATGATCGACTTCGCGCTGGCCGCCGAGCGCGAGCAGGGCATGCCGCCGCGGGAGGCGATCTACCAGGCCTGTCTGCTCCGCTTCCGACCGATCCTGATGACCACCCTCGCCGCCCTGCTCGGCGCCCTGCCGCTGATGCTGAGCACCGGCGTCGGCGCGGAGCTGCGGCGTCCGTTGGGGATCGGCATGGTTGGCGGCCTGATGCTCAGCCAGGTGCTGACCCTGTTCACCACCCCGGTGATCTATCTGCTGTTCGACCGCCTGTCGCTGCACCTGAAGCGCCGCTTCCCGCGTCAGGAAGAGGAGGCGTAA	MQVLPPGRTGGPSRLFIMRPVATTLLMVAILLAGIIGYRFLPVSALPEVDYPTIQVVTLYPGASPDVVTSAITAPLERQFGQMSGLKQMSSQSSGGASVVTLQFQLTLPLDVAEQEVQAAINAATNLLPNDLPNPPVYSKVNPADPPIMTLAVTSSAIPMTQVEDMVETRVAQKISQVSGVGLVTLAGGQRPAVRVKLNAQAIAALGLTSETVRTAITSANVNSAKGSLDGPARAVTLSANDQMQSAEDYRRLIIAYQNGAPIRLGDVASVEQGAENSWLGAWANQQRAIVMNVQRQPGANIIDTADSIRQMLPQLTESLPKSVKVQVLSDRTTNIRASVRDTQFELMLAIALVVMIIYLFLRNVPATIIPGVAVPLSLVGTFAVMVFLDFSINNLTLMALTIATGFVVDDAIVVIENISRYIEKGEKPLAAALKGAGEIGFTIISLTFSLIAVLIPLLFMGDIVGRLFREFAVTLAVAILISAVVSLTLTPMMCARMLSHESLRKQNRFSRASERFFDRVIAVYGRWLSRVLNHPWLTLGVALSTLALSILLWVFIPKGFFPIQDNGIIQGTLQAPQSVSFASMAQRQQQVSDIILKDPAVESLTSFVGVDGTNPALNSARLQINLKPLDERDDRVQTVISRLQQAVAGVPGVALYLQPTQDLTIDTTVSRTQYQFTLQANSLEALSTWVPPLLSRLQAQPQLADVSSDWQDKGLAAYIKVDRDSASRLGISMADVDNALYNAFGQRLISTIYTQANQYRVVLEQDTEATPGLAALDNIRLTSSDGGIVPLTAIATVEQRFTPLSVNHLDQFPVTTISFNVPDNYSLGEAVEAILTAEQSLDFPSDIRTQFQGSSLAFQSALGSTVWLVVAAVVAMYIVLGVLYESFIHPITILSTLPTAGVGALLALWLAGSELDVIAIIGIILLIGIVKKNAIMMIDFALAAEREQGMPPREAIYQACLLRFRPILMTTLAALLGALPLMLSTGVGAELRRPLGIGMVGGLMLSQVLTLFTTPVIYLLFDRLSLHLKRRFPRQEEEA	MQVLPPSSTGGPSRLFIMRPVATTLLMVAILLAGIIGYRALPVSALPEVDYPTIQVVTLYPGASPDVMTSAVTAPLERQFGQMSGLKQMSSQSSGGASVITLQFQLTLPLDVAEQEVQAAINAATNLLPSDLPNPPVYSKVNPADPPIMTLAVTSTAMPMTQVEDMVETRVAQKISQISGVGLVTLSGGQRPAVRVKLNAQAIAALGLTSETVRTAITGANVNSAKGSLDGPSRAVTLSANDQMQSAEEYRQLIIAYQNGAPIRLGDVATVEQGAENSWLGAWANKEQAIVMNVQRQPGANIISTADSIRQMLPQLTESLPKSVKVTVLSDRTTNIRASVDDTQFELMMAIALVVMIIYLFLRNIPATIIPGVAVPLSLIGTFAVMVFLDFSINNLTLMALTIATGFVVDDAIVVIENISRYIEKGEKPLAAALKGAGEIGFTIISLTFSLIAVLIPLLFMGDIVGRLFREFAITLAVAILISAVVSLTLTPMMCARMLSQESLRKQNRFSRASEKMFDRIIAAYGRGLAKVLNHPWLTLSVALSTLLLSVLLWVFIPKGFFPVQDNGIIQGTLQAPQSSSFANMAQRQRQVADVILQDPAVQSLTSFVGVDGTNPSLNSARLQINLKPLDERDDRVQKVIARLQTAVDKVPGVDLFLQPTQDLTIDTQVSRTQYQFTLQATSLDALSTWVPQLMEKLQQLPQLSDVSSDWQDKGLVAYVNVDRDSASRLGISMADVDNALYNAFGQRLISTIYTQANQYRVVLEHNTENTPGLAALDTIRLTSSDGGVVPLSSIAKIEQRFAPLSINHLDQFPVTTISFNVPDNYSLGDAVQAIMDTEKTLNLPVDITTQFQGSTLAFQSALGSTVWLIVAAVVAMYIVLGILYESFIHPITILSTLPTAGVGALLALLIAGSELDVIAIIGIILLIGIVKKNAIMMIDFALAAEREQGMSPREAIYQACLLRFRPILMTTLAALLGALPLMLSTGVGAELRRPLGIGMVGGLIVSQVLTLFTTPVIYLLFDRLALWTKSRFARHEEEA	100.00	gnl|BL_ORD_ID|755|hsp_num:0	820			0	3120	novobiocin
CCI165_S85_contig_19_30 # 40753 # 43830 # 1 # ID=1_30;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.637	CCI165_S85_contig_19_30	40753	43830	+	Strict	1800	1863.2	mdtC	91.61	3000794	protein homolog model	n/a	n/a	aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGAAGTTTTTCGCCCTCTTCATTTACCGCCCGGTGGCGACGATCCTCATCTCGCTGGCCATCACCCTGTGCGGCATTCTCGGCTTCCGGCTGCTGCCGGTGGCCCCGCTGCCGCAGGTCGATTTCCCGGTGATTATGGTCAGCGCCTCGCTGCCGGGGGCCTCGCCGGAGACCATGGCCTCGTCGGTGGCCACCCCGCTGGAGCGCTCCCTGGGGCGGATTGCCGGGGTCAATGAGATGACCTCCTCCAGTTCACTCGGCAGCACCCGCATCATTCTCGAGTTTAACTTCGACCGCGATATCAACGGCGCGGCGCGCGATGTCCAGGCAGCGATCAACGCCGCGCAAAGTCTGCTGCCGAGCGGGATGCCCAGCCGGCCGACCTACCGCAAAGCCAACCCGTCGGATGCGCCGATCATGATCCTGACGCTGACCTCCGACACCTACTCCCAGGGTGAGCTGTATGATTTCGCCTCCACCCAGCTGGCGCAGACCATCGCGCAGATTGACGGCGTCGGCGATGTCGACGTCGGCGGCAGCTCCCTGCCGGCGGTGCGCGTCGACCTCAACCCGCAGGCGCTGTTCAACCAGGGCGTGTCGCTGGACGCGGTGCGCACCGCCATCAGCGACGCCAACGTGCGCAAGCCGCAGGGGGCGCTGGAGGACAGCGCCCACCGCTGGCAGGTGCATACCAACGATGAGCTGAAGACCGCCGCCGACTATCAGCCGCTGATCGTCCACTACCAGAACGGCGCCGCGGTGCGGCTGGGGGATGTCGCCACCGTCTCAGATTCGGTGCAGGACGTGCGCAACGCCGGGATGACCAACGCCAAGCCGGCGATCCTGCTGATGATCCGCAAACTGCCGGAAGCCAATATTATTCAGACGGTGGACAGCATCCGCGCCCGCCTGCCGGAGCTGCAGCAGACCATCCCGGCGGCCATCGACCTGCAGATCGCCCAGGATCGCTCGCCGACCATCCGCGCCTCGCTGGAGGAGGTGGAGCAGACGCTGGTGATTTCGGTGGCGCTGGTGATCCTGGTGGTGTTCCTGTTCCTGCGCTCCGGACGCGCCACGCTGATCCCCGCCGTCGCCGTTCCGGTTTCCTTAATCGGCACCTTCGCCGCGATGTACTTATGCGGTTTCAGCCTCAATAACCTGTCGCTGATGGCCCTGACTATCGCCACCGGCTTCGTGGTGGATGACGCCATCGTGGTGCTGGAGAATATCTCCCGCCATCTGGAGGCGGGGATGAAACCGCTGCAGGCGGCGCTGCAGGGAAGCCGCGAGGTCGGCTTTACCGTCCTGTCGATGAGCTTGTCGCTGGTGGCGGTGTTTCTGCCGCTGCTGCTGATGGGCGGCCTGCCCGGCCGCCTGCTGCGCGAGTTCGCCGTCACCCTGTCGGTGGCGATCGGCATCTCGCTGGCGGTCTCCCTCACCCTGACGCCGATGATGTGCGGCTGGCTGCTGAAAAGCGGCAAACCCCACCAGCCGACGCGCAACCGCGGCTTTGGCCGCCTGCTGGTGGCCGTACAGGGCGGCTATGGTAAATCGTTAAAATGGGTGCTGAAGCACAGCCGCCTGACCGGCCTGGTGGTGCTGGGCACCATCGCCCTCAGCGTCTGGCTCTATATCTCGATCCCGAAAACCTTCTTCCCGGAGCAGGACACCGGCGTTCTGATGGGCGGCATTCAGGCCGACCAGAGCATCTCCTTCCAGGCGATGCGCGGCAAGCTGCAGGACTTTATGAAAATCATTCGCGAAGATCCGGCGGTGGATAACGTCACCGGATTTACCGGCGGCTCGCGGGTCAACAGCGGGATGATGTTTATCACCCTCAAGCCGCGCGACCAGCGCCACGAGACGGCGCAGCAGGTGATCGACCGGCTGCGCAAAAAGCTGGCCAACGAGCCCGGGGCTAACCTGTTCCTGATGGCGGTGCAGGATATCCGCGTCGGTGGCCGGCAGTCGAACGCCAGCTATCAGTACACCCTGCTGTCCGATGACCTGTCGGCGCTGCGCGAGTGGGAGCCCAAGATCCGCAAAGCGCTGGCGGCGCTGCCTGAGCTGGCGGACGTCAACTCGGATCAGCAGGACAATGGCGCCGAAATGGACCTGGTCTATGACCGGGATACCATGTCGCGCCTCGGCATCAGCGTTCAGGACGCCAACAACCTGCTGAACAACGCCTTCGGCCAGCGGCAGATCTCCACCATCTACCAGCCGCTTAACCAGTACAAGGTGGTGATGGAGGTGGATCCGGCCTACACCCAGGACGTCAGCGCCCTGGATAAGATGTTTGTCATCAACAGCGAGGGCAAGCCGATCCCGCTGGCCTACTTCGCCAAATGGCAGCCGGCCAACGCCCCGCTGTCGGTGAACCACCAGGGGCTGTCGGCGGCGTCCACAATCTCCTTTAACCTGCCCACCGGCCGCTCGCTGTCGGAAGCCAGCGAGGCGATTAACCGCGCGATGACCCAGCTCGGGGTGCCGTCCACCGTACGTGGCTCCTTTGCCGGTACCGCTCAGGTGTTCCAGCAGACCATGAACGCGCAGGTGATCCTGATCCTCGCGGCCATTGCCACGGTCTATATCGTGCTGGGGATGCTCTACGAGAGCTATGTACATCCGTTGACCATCCTTTCGACGCTACCCTCCGCCGGGGTGGGCGCGCTGCTGGCGCTGGAGATATTCGATGCCCCGTTCAGCCTAATCGCCCTTATCGGGATCATGTTATTAATTGGCATCGTGAAGAAAAACGCCATCATGATGGTTGATTTTGCCCTTGAGGCGCAGCGCACCGGCAACCTGACGCCGGAAGAGGCGATTTTCCAGGCCTGCCTGCTGCGTTTCCGGCCGATTATGATGACCACCCTCGCCGCGCTGTTCGGCGCCCTGCCGCTGGTGCTCTCCGGCGGCGACGGCTCCGAACTGCGCCAGCCGCTGGGGATCACTATCGTCGGCGGTCTGGTGATGAGCCAGCTGTTAACGCTCTACACCACGCCGGTGGTCTATCTTTTCTTTGACCGTTTGCGGCTGCGTTTTTCGCGTCATTCCACTCAACCGGTAAGCGAATAA	MKFFALFIYRPVATILISLAITLCGILGFRLLPVAPLPQVDFPVIMVSASLPGASPETMASSVATPLERSLGRIAGVNEMTSSSSLGSTRIILEFNFDRDINGAARDVQAAINAAQSLLPSGMPSRPTYRKANPSDAPIMILTLTSDTYSQGELYDFASTQLAQTIAQIDGVGDVDVGGSSLPAVRVDLNPQALFNQGVSLDAVRTAISDANVRKPQGALEDSAHRWQVHTNDELKTAADYQPLIVHYQNGAAVRLGDVATVSDSVQDVRNAGMTNAKPAILLMIRKLPEANIIQTVDSIRARLPELQQTIPAAIDLQIAQDRSPTIRASLEEVEQTLVISVALVILVVFLFLRSGRATLIPAVAVPVSLIGTFAAMYLCGFSLNNLSLMALTIATGFVVDDAIVVLENISRHLEAGMKPLQAALQGSREVGFTVLSMSLSLVAVFLPLLLMGGLPGRLLREFAVTLSVAIGISLAVSLTLTPMMCGWLLKSGKPHQPTRNRGFGRLLVAVQGGYGKSLKWVLKHSRLTGLVVLGTIALSVWLYISIPKTFFPEQDTGVLMGGIQADQSISFQAMRGKLQDFMKIIREDPAVDNVTGFTGGSRVNSGMMFITLKPRDQRHETAQQVIDRLRKKLANEPGANLFLMAVQDIRVGGRQSNASYQYTLLSDDLSALREWEPKIRKALAALPELADVNSDQQDNGAEMDLVYDRDTMSRLGISVQDANNLLNNAFGQRQISTIYQPLNQYKVVMEVDPAYTQDVSALDKMFVINSEGKPIPLAYFAKWQPANAPLSVNHQGLSAASTISFNLPTGRSLSEASEAINRAMTQLGVPSTVRGSFAGTAQVFQQTMNAQVILILAAIATVYIVLGMLYESYVHPLTILSTLPSAGVGALLALEIFDAPFSLIALIGIMLLIGIVKKNAIMMVDFALEAQRTGNLTPEEAIFQACLLRFRPIMMTTLAALFGALPLVLSGGDGSELRQPLGITIVGGLVMSQLLTLYTTPVVYLFFDRLRLRFSRHSTQPVSE	MKFFALFIYRPVATILLSVAITLCGILGFRMLPVAPLPQVDFPVIIVSASLPGASPETMASSVATPLERSLGRIAGVSEMTSSSSLGSTRIILQFDFDRDINGAARDVQAAINAAQSLLPSGMPSRPTYRKANPSDAPIMILTLTSDTYSQGELYDFASTQLAPTISQIDGVGDVDVGGSSLPAVRVGLNPQALFNQGVSLDDVRTAVSNANVRKPQGALEDGTHRWQIQTNDELKTAAEYQPLIIHYNNGGAVRLGDVATVTDSVQDVRNAGMTNAKPAILLMIRKLPEANIIQTVDSIRAKLPELQETIPAAIDLQIAQDRSPTIRASLEEVEQTLIISVALVILVVFLFLRSGRATIIPAVSVPVSLIGTFAAMYLCGFSLNNLSLMALTIATGFVVDDAIVVLENIARHLEAGMKPLQAALQGTREVGFTVLSMSLSLVAVFLPLLLMGGLPGRLLREFAVTLSVAIGISLLVSLTLTPMMCGWMLKASKPREQKRLRGFGRMLVALQQGYGKSLKWVLNHTRLVGVVLLGTIALNIWLYISIPKTFFPEQDTGVLMGGIQADQSISFQAMRGKLQDFMKIIRDDPAVDNVTGFTGGSRVNSGMMFITLKPRDERSETAQQIIDRLRVKLAKEPGANLFLMAVQDIRVGGRQSNASYQYTLLSDDLAALREWEPKIRKKLATLPELADVNSDQQDNGAEMNLVYDRDTMARLGIDVQAANSLLNNAFGQRQISTIYQPMNQYKVVMEVDPRYTQDISALEKMFVINNEGKAIPLSYFAKWQPANAPLSVNHQGLSAASTISFNLPTGKSLSDASAAIDRAMTQLGVPSTVRGSFAGTAQVFQETMNSQVILIIAAIATVYIVLGILYESYVHPLTILSTLPSAGVGALLALELFNAPFSLIALIGIMLLIGIVKKNAIMMVDFALEAQRHGNLTPQEAIFQACLLRFRPIMMTTLAALFGALPLVLSGGDGSELRQPLGITIVGGLVMSQLLTLYTTPVVYLFFDRLRLRFSRKPKQTVTE	100.00	gnl|BL_ORD_ID|1210|hsp_num:0	1315			0	3075	novobiocin
CCI165_S85_contig_19_81 # 100957 # 102396 # -1 # ID=1_81;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.617	CCI165_S85_contig_19_81	100957	102396	-	Strict	900	957.977	MdtQ	98.33	3007682	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; cephamycin; penam; penem	reduced permeability to antibiotic	Outer Membrane Porin (Opr)	ATGAAATTGATATTAAAAAATAGCGTGCTGGCGGCGTTGCCCCTGGCCATCGCGCTGGCTGGCTGCGCGCCTTCTCATGAGGTCGCTAATCCGCCGCAGCAGCAAATTCCGGCTTCCCACGTTTCCATGGATCTTCCCGCCGCCGTCAAAAATGGCTGGCCACACACCGACTGGTGGAAAGACTACCACGATGCCCAACTGGATAATCTGATTCAGCGCGCACTCGCCAACGCGCCGGACATGCAGATTGCCGAACAGCGCATCAGGCTTGCTGAAGCGCAGGCGCGAATGTCGCAGGCGAATCTTGGCCCGGAGATGGATTTCTCCGCCGATATCGAACGGCAGAAAATGTCCGCTGAAGGCCTGATGGGGCCGTTCGCCACCGATACCGACGGCAATACCGGCCCGTGGTACACCAATGGCACCTTCGGCCTGACTGCCGGCTGGGATCTCGATCTGTGGGGCAAAAACCGCGCGCTGGTGAAAGCGCGCATCGGCGAGCTGAAAGCCCAGGTGGCCGAGCAGGCCCAGACCCGCGAGCTGCTCTCCGGCAGCGTGGCGCGCCTGTACTGGCAGTGGCAGACGGAAGCGGCGATCAAAGCGGTGCTGCAGCAGGTGAAAAACGAGCAAAATAATATCGTGACGGTCGACAAGGCCCTGTATCAGCGCGGGATCACCAACTCCGCCGAAGGGGCGGAGAACGATATTAACGTCAGCAAAACCGACCAGCAGCTGGCGGACGTGGCGGGCACGATGAAAGAGATTGAAGCGCGGCTGATGGCCCTGACCAACAGCCAGAGCCAGTCGCTGAACCTCAAACCCGCCAGCCTGCCGACGGTCAGCGCGCAGCTGCCGGATACCCTCGGCTATGAGCTGCTGGCGCGCCGCCCGGATCTGCAGGTCGCTCACTGGTATATCGAGGCGTCGCTGAGCGAAGTGGACGCGGCGAAGGCGGCGTTTTATCCGGACATCAACCTGATGGCGTTCCTGCAGCAGGATGCCCTGCACTTAAGCGATCTTTTCCGCCATTCGGCGCAGCAGATGGGCGTCACCGCCGGACTGACGCTGCCGATCTTCGACAGCGGTCGTCTCAATGCTAATCTGGATATCGCCAGCGCGCAGAACAGCCTGTCCATCGCCCAATACAACAAAGCGGTGGTGGACGCCGTCAACCAGGTGGCGAAAACCGCCAGCCAGGTTGAGACGCTGATGGCCAAAAGCCAACAGCAGCAGCAGGTTGAAAAAGACGCCCAGCGGGTGGTGGATCTGGCGCAGGCCCGAATGGCGGCGGGGATCCTGCCCGGCTCCAGGGTGAGCCTGGCGAAACTCCCGGCGCTGCAGGAGCGTATCACCGCCTTGCGCCTGCACGGCCAGTGGATTGACGCCAGCATTCAGCTGACCTCGGCCCTTGGCGGCGGCTACCATCAGACGGTGAAGTAA	MKLILKNSVLAALPLAIALAGCAPSHEVANPPQQQIPASHVSMDLPAAVKNGWPHTDWWKDYHDAQLDNLIQRALANAPDMQIAEQRIRLAEAQARMSQANLGPEMDFSADIERQKMSAEGLMGPFATDTDGNTGPWYTNGTFGLTAGWDLDLWGKNRALVKARIGELKAQVAEQAQTRELLSGSVARLYWQWQTEAAIKAVLQQVKNEQNNIVTVDKALYQRGITNSAEGAENDINVSKTDQQLADVAGTMKEIEARLMALTNSQSQSLNLKPASLPTVSAQLPDTLGYELLARRPDLQVAHWYIEASLSEVDAAKAAFYPDINLMAFLQQDALHLSDLFRHSAQQMGVTAGLTLPIFDSGRLNANLDIASAQNSLSIAQYNKAVVDAVNQVAKTASQVETLMAKSQQQQQVEKDAQRVVDLAQARMAAGILPGSRVSLAKLPALQERITALRLHGQWIDASIQLTSALGGGYHQTVK	MKLILNKSVLAALPLAIALAGCAPSHEVANPPQQQIPASHVSMDLPAAVKNGWPQTDWWKDYHDPQLNNLIQRALANAPDMQIAEQRIRLAEAQARMSQANLGPEMDFSADIERQRMSAEGLMGPFATDTDGNTGPWYTNGTFGLTAGWDLDLWGKNRALVKARIGELKAQVAEQAQTRELLSGSVARLYWQWQTEAAIKAVLQQVKNEQNNIVTVDKALYQRGITNSAEGAENDINVSKTDQQLADVTGTMKEIEARLMALTNSQSQSLNLKPASLPTVSAQLPDTLGYELLARRPDLQVAHWYIEASLSEVDAAKAAFYPDINLMAFLQQDALHLSDLFRHSAQQMGVTAGLTLPIFDSGRLNANLDIASAQNSLSIAQYNKAVVDAVNQVAKTASQVETLMAKSQQQQQVEKDAQRVVDLAQARMAAGILPGSRVSMAKLPALQERITALRLHGQWIDASIQLTSALGGGYHQTVK	100.00	gnl|BL_ORD_ID|5014|hsp_num:0	6011			0	1437	
CCI165_S85_contig_1_52 # 56021 # 57091 # 1 # ID=1_52;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.550	CCI165_S85_contig_1_52	56021	57091	+	Strict	700	725.702	OmpA	98.88	3005044	protein homolog model	n/a	n/a	peptide antibiotic	reduced permeability to antibiotic	General Bacterial Porin with reduced permeability to peptide antibiotics	ATGAAAAAGACAGCTATCGCGATTGCAGTGGCACTGGCTGGCTTCGCTACCGTAGCGCAGGCCGCTCCGAAAGATAACACCTGGTATGCAGGTGGTAAACTGGGTTGGTCCCAGTATCACGATACCGGTTTCTACGGTAACGGTTTCCAGAACAACAATGGTCCGACCCGTAACGATCAGCTTGGTGCTGGTGCGTTCGGTGGTTACCAGGTTAACCCGTACCTCGGTTTCGAAATGGGTTATGACTGGCTGGGCCGTATGGCATATAAAGGCAGCGTTGATAACGGTGCTTTCAAAGCTCAGGGCGTTCAGCTGACCGCTAAACTGGGTTACCCGATCACTGACGATCTGGATATCTACACCCGTCTGGGCGGCATGGTTTGGCGCGCTGACTCCAAAGGCAACTACGCTTCCACCGGCGTTTCCCGTAGCGAACACGACACTGGCGTTTCCCCAGTATTTGCTGGCGGCGTAGAGTGGGCTGTTACTCGTGACATCGCTACCCGTCTGGAATACCAGTGGGTTAACAACATCGGCGACGCTGGCACTGTTGGTACCCGTCCTGATAACGGCATGCTGAGCCTGGGTGTTTCCTACCGTTTCGGTCAGGAAGATGCTGCACCGGTTGTAGCTCCGGCTCCGGCTCCGGCTCCGGAAGTGGCTACCAAGCACTTCACCCTGAAGTCTGACGTACTGTTCAACTTCAACAAAGCGACCCTGAAACCGGAAGGTCAGCAGGCTCTGGATCAGCTGTACACCCAGCTGAGCAACATGGATCCGAAAGACGGTTCCGCAGTTGTCATGGGCTTCACCGACCGTATCGGTTCCGAAGCTTACAACCAGCAGCTGTCTGAGAAACGTGCTCAGTCCGTTGTTGACTACCTGGTTGCTAAAGGCATCCCGGCTGGCAAAATCTCCGCTCGCGGCATGGGTAAATCCAATCCGGTTACTGGCAACACCTGTGACAACGTGAAAGCTCGCGCTGCCCTGATCGACTGCCTGGCTCCGGATCGTCGTGTAGAGATCGAAGTTAAAGGCTACAAAGAAGTTGTAACTCAGCCTGCGGCTTAA	MKKTAIAIAVALAGFATVAQAAPKDNTWYAGGKLGWSQYHDTGFYGNGFQNNNGPTRNDQLGAGAFGGYQVNPYLGFEMGYDWLGRMAYKGSVDNGAFKAQGVQLTAKLGYPITDDLDIYTRLGGMVWRADSKGNYASTGVSRSEHDTGVSPVFAGGVEWAVTRDIATRLEYQWVNNIGDAGTVGTRPDNGMLSLGVSYRFGQEDAAPVVAPAPAPAPEVATKHFTLKSDVLFNFNKATLKPEGQQALDQLYTQLSNMDPKDGSAVVMGFTDRIGSEAYNQQLSEKRAQSVVDYLVAKGIPAGKISARGMGKSNPVTGNTCDNVKARAALIDCLAPDRRVEIEVKGYKEVVTQPAA	MRSFVTSWRILDDNEAQKMKKTAIAIAVALAGFATVAQAAPKDNTWYAGGKLGWSQYHDTGFYGNGFQNNNGPTRNDQLGAGAFGGYQVNPYLGFEMGYDWLGRMAYKGSVDNGAFKAQGVQLTAKLGYPITDDLDIYTRLGGMVWRADSKGNYASTGVSRSEHDTGVSPVFAGGVEWAVTRDIATRLEYQWVNNIGDAGTVGTRPDNGMLSLGVSYRFGQEDAAPVVAPAPAPAPEVATKHFTLKSDVLFNFNKATLKPEGQQALDQLYTQLSNMDPKDGSAVVLGYTDRIGSEAYNQQLSEKRAQSVVDYLVAKGIPAGKISARGMGESTPVTGNTCDNVKARAALIDCLAPDRRVEIEVKGYKEVVTQPAA	95.19	gnl|BL_ORD_ID|2780|hsp_num:0	3787			54	1122	polymyxin B; defensin
CCI165_S85_contig_1_88 # 100631 # 102379 # -1 # ID=1_88;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.560	CCI165_S85_contig_1_88	100631	102379	-	Strict	1000	1125.15	msbA	92.61	3003950	protein homolog model	n/a	n/a	nitroimidazole antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGCAGAACGATAAAGATCTCTCCACGTGGCAGACCTTCCGCCGACTTTGGCCGATTATTGCACCGTTTAAAGCCGGGCTAATCGTAGCGGCGGTGGCGTTAGTGCTTAACGCGGGCAGTGACACCTTCATGTTATCGCTTCTTAAACCGTTATTGGATGATGGTTTTGGTAAAACGGATCGCTCAGTGCTGCTATGGATGCCGCTGGTGGTTATCGGGCTGATGGTGCTGCGTGGGATCACCAGCTACATCTCGAGCTATTGTATCTCCTGGGTTTCCGGCAAAGTGGTGATGACCATGCGTCGTCGCCTGTTCGGCCACATGATGGGCATGCCGGTGGCTTTCTTTGACAAGCAGTCTACCGGGACGCTGCTGTCACGTATCACCTATGATTCTGAACAGGTCGCTTCCTCCTCTTCCAGCGCGCTGATCACCGTGGTCCGCGAAGGGGCATCGATTATCGGCCTGTTCGTGATGATGTTCTATTACAGCTGGCAGCTGTCGTTGATCCTAATTGTACTGGCGCCGATCGTGTCGGTAGCAATCCGCGTGGTCTCCAAGCGTTTTCGCAATATCAGTAAGAATATGCAGAACACGATGGGGCAGGTCACCACCAGCGCTGAGCAGATGCTGAAAGGGCACAAAGAGGTGCTGATGTTTGGCGGCCAGGAAGTGGAAACCAAACGTTTTGATAAGGTCAGCAATAAAATGCGCCTGCAGGGGATGAAAATGGTTTCCGCCTCGTCTATCTCCGACCCGATCATTCAGCTTATCGCCTCCCTGGCGCTGGCCTTTGTCCTGTATGCCGCCAGCTTCCCGAGCGTGATGGACACCCTGACCGCTGGGACCATTACCGTGGTCTTCTCCTCCATGATTGCGCTGATGCGTCCGCTGAAGTCTCTGACCAACGTCAATGCCCAGTTCCAGCGCGGGATGGCGGCATGCCAGACGCTGTTTGCGATCCTCGATTCCGAGCAGGAGAAAGACGAAGGTACCCGCGTCATTGAGCGGGCGAAAGGCAATCTCAAGTTCGAGAACGTCACCTTTACCTATCCGGGTCGCGAAGTGGCCGCGCTGCGCAATATCAATCTCGATATCCCGGAAGGGAAAACCGTGGCGCTGGTGGGACGCTCCGGTTCGGGTAAATCGACCATCGCCAGCCTGATCACGCGCTTCTACGATGTCGACGATGGGCAGATCCTGCTGGATGGCCATGACTTGCGCGAGTACAAGCTGAGCTCGCTGCGCGACCAGGTAGCGCTGGTTTCACAGAACGTGCACCTGTTCAATGATACCGTCGCCAATAACATCGCCTATGCCCGTACTGAAGAGTACAGCCGCGAGCAGATTGAAGAGGCTGCGCGAATGGCCTACGCCATGGACTTCATCAACAAGATGGACAATGGCCTGGATACCATCATCGGCGAAAATGGCGTGATGCTGTCCGGCGGCCAGCGCCAGCGTATTGCTATCGCCCGTGCGCTACTGCGTAACAGCCCGATCCTGATCCTCGATGAAGCCACCTCGGCGCTGGATACCGAGTCCGAGCGTGCGATTCAGGCGGCGCTGGATGAGCTGCAGAAAAATCGCACCTCGCTGGTTATTGCCCACCGTCTGTCAACCATTGAGCAGGCTGATGAGATTGTGGTGGTTGAAGACGGGCGGATCGTGGAGCGCGGAACGCACCACGACCTGCTGGAGCATAAAGGCGTATACGCCCAGCTGCATAAGATGCAATTCGGCGAATGA	MQNDKDLSTWQTFRRLWPIIAPFKAGLIVAAVALVLNAGSDTFMLSLLKPLLDDGFGKTDRSVLLWMPLVVIGLMVLRGITSYISSYCISWVSGKVVMTMRRRLFGHMMGMPVAFFDKQSTGTLLSRITYDSEQVASSSSSALITVVREGASIIGLFVMMFYYSWQLSLILIVLAPIVSVAIRVVSKRFRNISKNMQNTMGQVTTSAEQMLKGHKEVLMFGGQEVETKRFDKVSNKMRLQGMKMVSASSISDPIIQLIASLALAFVLYAASFPSVMDTLTAGTITVVFSSMIALMRPLKSLTNVNAQFQRGMAACQTLFAILDSEQEKDEGTRVIERAKGNLKFENVTFTYPGREVAALRNINLDIPEGKTVALVGRSGSGKSTIASLITRFYDVDDGQILLDGHDLREYKLSSLRDQVALVSQNVHLFNDTVANNIAYARTEEYSREQIEEAARMAYAMDFINKMDNGLDTIIGENGVMLSGGQRQRIAIARALLRNSPILILDEATSALDTESERAIQAALDELQKNRTSLVIAHRLSTIEQADEIVVVEDGRIVERGTHHDLLEHKGVYAQLHKMQFGE	MHNDKDLSTWQTFRRLWPTIAPFKAGLIVAGVALILNAASDTFMLSLLKPLLDDGFGKTDRSVLVWMPLVVIGLMILRGITSYVSSYCISWVSGKVVMTMRRRLFGHMMGMPVSFFDKQSTGTLLSRITYDSEQVASSSSGALITVVREGASIIGLFIMMFYYSWQLSIILIVLAPIVSIAIRVVSKRFRNISKNMQNTMGQVTTSAEQMLKGHKEVLIFGGQEVETKRFDKVSNRMRLQGMKMVSASSISDPIIQLIASLALAFVLYAASFPSVMDSLTAGTITVVFSSMIALMRPLKSLTNVNAQFQRGMAACQTLFTILDSEQEKDEGKRVIERATGDVEFRNVTFTYPGRDVPALRNINLKIPAGKTVALVGRSGSGKSTIASLITRFYDIDEGEILMDGHDLREYTLASLRNQVALVSQNVHLFNDTVANNIAYARTEQYSREQIEEAARMAYAMDFINKMDNGLDTVIGENGVLLSGGQRQRIAIARALLRDSPILILDEATSALDTESERAIQAALDELQKNRTSLVIAHRLSTIEKADEIVVVEDGVIVERGTHNDLLEHRGVYAQLHKMQFGQ	100.00	gnl|BL_ORD_ID|2184|hsp_num:0	2423			0	1746	metronidazole
CCI165_S85_contig_1_156 # 181734 # 182966 # -1 # ID=1_156;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.613	CCI165_S85_contig_1_156	181734	182966	-	Strict	700	701.819	Escherichia coli mdfA	85.12	3001328	protein homolog model	n/a	n/a	tetracycline antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCAAAATTATTCGCTTTCAGGTCGCCGCCTCGGAAGGCAGGCGCTGCTGTTCCCGCTATGTCTGGTGCTGTACGAGTTTTCCACCTATATCGGCAACGATATGATCCAGCCGGGTATGCTGGCCGTGGTTCAGGAGTTTCAGGTGGGCAACGAGTGGGTACCCACCTCGATGACCGCTTATCTGGCCGGCGGCATGTTTCTACAGTGGCTGCTGGGGCCGCTGTCGGACCGTATTGGCCGCCGTCCGGTGATGTTGACCGGGGTGGTGTGGTTTATCGTCACCTGCCTGGCGACGTTGCTGGCGCAGACCATTGAACAGTTCACCCTGCTGCGCTTCCTGCAGGGGATCAGCCTGTGTTTTATCGGCGCGGTCGGCTACGCGGCGATCCAGGAGTCCTTTGAGGAGGCGGTGTGTATTAAAATCACCGCCCTGATGGCCAACGTGGCGCTGATTGCCCCGCTGCTGGGGCCGCTGGTGGGCGCCGCCTGGGTGCATATCCTGCCGTGGGAGATGATGTTCGTGCTGTTCGCCGTGCTGGCGGCTATCTCGTTTGTCGGCCTGCAGCGGGCGATGCCGGAAACCGCGACGCGACTGGGTGAAAAGCTGTCGGTCAAAGAGCTGGGCCGCGACTATCGGCTGGTGCTAAAGAACCTGCGCTTCGTCGCCGGCGCGCTGGCTACCGGCTTTGTCAGCCTGCCGCTGCTGGCGTGGATCGCCCAGTCGCCGGTGATTATTATCAGCGGCGAACAGGCGACAAGCTATGAGTATGGCATGCTGCAGGTGCCGATTTTCGGCGCGCTGATTGCCGGCAACCTGGTGCTGGCGCGCCTGACTTCGCGCCGTACCGTGCGCTCGCTGATTATCATGGGCGGCTGGCCTATCGTGTTTGGCCTGCTCCTCTCCGCGGTGGCGACGGTGGTCTCTTCCCACGCCTATCTGTGGATGACCGCCGGTCTGAGCTTCTACGCCTTCGGGATTGGCCTGGCGAACGCCGGCCTGGTGCGCTTAACCCTGTTCGCCAGCGAGATGAGCAAAGGCACGGTTTCGGCGGCGATGGGGATGCTGCAGATGCTGATCTTCACCGTCGGCATCGAGCTCAGCAAACATGCTTACGAGCTCGGCGGCAACGGGCTGTTCAGCCTGTTTAACCTGTTGGGCGGGGTACTGTGGCTGGGGCTGATGATCTACTTCCTGAAAGATAAAAGCGTCGGCAATTCGCAGCAGGGATAA	MQNYSLSGRRLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVQEFQVGNEWVPTSMTAYLAGGMFLQWLLGPLSDRIGRRPVMLTGVVWFIVTCLATLLAQTIEQFTLLRFLQGISLCFIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWVHILPWEMMFVLFAVLAAISFVGLQRAMPETATRLGEKLSVKELGRDYRLVLKNLRFVAGALATGFVSLPLLAWIAQSPVIIISGEQATSYEYGMLQVPIFGALIAGNLVLARLTSRRTVRSLIIMGGWPIVFGLLLSAVATVVSSHAYLWMTAGLSFYAFGIGLANAGLVRLTLFASEMSKGTVSAAMGMLQMLIFTVGIELSKHAYELGGNGLFSLFNLLGGVLWLGLMIYFLKDKSVGNSQQG	MQNKLASGARLGRQALLFPLCLVLYEFSTYIGNDMRQPGMLENVEQYQAGIEWVPTSMNAYLAGGMFIQWLLGPLSDRIGRRPVMLAGVVWFIVTCLAILLAQNIEQFTLLRFLHGISLCFIGAVGYDAIQESFEEAVCIKITALMANVALIAPLLGPLVGASWIHVLPWEGMFVLFAALAAISFFGLQRAMPETATRIGEKLSLKELGRDYKLVLKNGRFVAGALALGFLSLPLLAWIAQSPIIIITGEQLSSYEYGLLQVPIFGALIAGNLLLARLTSRRTVRSLIIMGGWPIMIGLLVAAAATVISSHAYLWMTAGLSIYAFGIGLANAGLVRLTLFASVMSKGTVSAAMGMLQMLIFTVGIEISKHAWLNGGNGLFNLFNLVNGILLLSLMVIFLKDKQMGNSHEG	100.00	gnl|BL_ORD_ID|2424|hsp_num:0	37			0	1230	tetracycline; chloramphenicol; thiamphenicol; benzalkonium chloride
CCI165_S85_contig_2_215 # 220754 # 221116 # 1 # ID=1_215;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.463	CCI165_S85_contig_2_215	220754	221116	+	Strict	150	220.705	Klebsiella pneumoniae KpnE	95.83	3004580	protein homolog model	n/a	n/a	macrolide antibiotic; aminoglycoside antibiotic; cephalosporin; tetracycline antibiotic; peptide antibiotic; rifamycin antibiotic; disinfecting agents and antiseptics	antibiotic efflux	small multidrug resistance (SMR) antibiotic efflux pump	ATGTTTTATTGGATTTTATTAGCTTTAGCTATTGTTGCTGAAATTACCGGCACGTTGTCGATGAAATGGGCAAGCATCAGCGGTGGGCATACCGGCTATATTTTAATGCTGGCCATGATAGCTCTGTCATATATTTTTCTCGCCTTTGCAGTTAAAAAAATTGCCCTCGGTGTGGCTTACGCGTTATGGGAAGGGATTGGCATTTTGCTGATCACCCTGTTCAGCGTTCTGTTATTTGATGAAAGCTTGTCGCTGCTGAAAATAGCCGGTCTGACCACACTGGTGGTGGGGATCGTCCTGATTAAGTCCGGCACCCAGAAAAAAGCGTCGTCGAAGCAGGAGGTGGCTCATGCAGCAGTTTGA	MFYWILLALAIVAEITGTLSMKWASISGGHTGYILMLAMIALSYIFLAFAVKKIALGVAYALWEGIGILLITLFSVLLFDESLSLLKIAGLTTLVVGIVLIKSGTQKKASSKQEVAHAAV	MFYWILLALAIIAEITGTLSMKWASVSGGHTGFILMLAMIALSYIFLAFAVKKIALGVAYALWEGIGILLITLFSVLLFDESLSLLKIAGLTTLVIGIVLIKSGTQKKASSQQEVAHAAV	100.00	gnl|BL_ORD_ID|2726|hsp_num:0	3283			0	360	erythromycin; streptomycin; tetracycline; cefepime; ceftriaxone; rifampin; colistin A; colistin B; triclosan; benzalkonium chloride; chlorhexidine
CCI165_S85_contig_2_216 # 221103 # 221432 # 1 # ID=1_216;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.585	CCI165_S85_contig_2_216	221103	221432	+	Strict	150	204.527	Klebsiella pneumoniae KpnF	98.17	3004583	protein homolog model	n/a	n/a	macrolide antibiotic; aminoglycoside antibiotic; cephalosporin; tetracycline antibiotic; peptide antibiotic; rifamycin antibiotic; disinfecting agents and antiseptics	antibiotic efflux	small multidrug resistance (SMR) antibiotic efflux pump	ATGCAGCAGTTTGAGTGGATCCACGCCGCCTGGTTGGCTATCGCCATTGTTCTGGAGATTATTGCCAACGTCTTTTTGAAGTTTTCCGACGGTTTCCGCCGCAAGGTCTATGGCATCCTGTCGCTGGCGGCGGTGCTGGGCGCATTCAGCGCCCTGTCGCAGGCGGTAAAAGGCATCGATCTGTCGGTTGCCTATGTGCTGTGGGGCGGCTTCGGTATCGCGGCGACCATCGCCGCCGGCTGGGTGCTGTTTGGCCAGCGCCTGAATAACAAAGGCTGGGCGGGAGTCATCCTGTTGGTTGCCGGCATGGTGTTAATTAAACTCGCCTGA	MQQFEWIHAAWLAIAIVLEIIANVFLKFSDGFRRKVYGILSLAAVLGAFSALSQAVKGIDLSVAYVLWGGFGIAATIAAGWVLFGQRLNNKGWAGVILLVAGMVLIKLA	MQQFEWIHAAWLAIAIVLEIIANVFLKFSDGFRRKIYGILSLAAVLGAFSALSQAVKGIDLSVAYALWGGFGIAATIAAGWVLFGQRLNNKGWAGVILLVAGMVLIKLA	100.00	gnl|BL_ORD_ID|2728|hsp_num:0	3286			0	327	erythromycin; streptomycin; tetracycline; cefepime; ceftriaxone; rifampin; colistin A; colistin B; triclosan; benzalkonium chloride; chlorhexidine
CCI165_S85_contig_2_258 # 263328 # 264188 # -1 # ID=1_258;partial=00;start_type=ATG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.653	CCI165_S85_contig_2_258	263328	264188	-	Perfect	525	578.17	OKP-B-17	100.0	3002450	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OKP beta-lactamase	ATGCGTTATGTTCGCCTGTGCCTTATCTCCCTGATTGCCGCCCTGCCACTGGCGGTATTCGCCAGCCCTCAGCCGCTTGAGCAGATTAAAATCAGCGAAGGTCAGCTGGCGGGCCGGGTGGGCTATGTTGAAATGGATCTGGCCAGCGGCCGCACGCTGGCCGCCTGGCGCGCCAGTGAGCGCTTTCCGCTGATGAGCACCTTTAAAGTGCTGCTCTGCGGCGCGGTGCTGGCCCGGGTGGATGCCGGCGACGAACAGCTGGATCGGCGGATCCACTACCGCCAGCAGGATCTGGTGGACTACTCCCCGGTCAGCGAAAAACACCTTGCCGACGGGATGACCGTTGGCGAACTCTGCGCCGCCGCCATCACCATGAGCGACAACAGCGCCGGCAATCTGCTGTTGAAGAGCGTCGGCGGCCCCGCGGGATTGACCGCTTTTCTGCGCCAGATCGGTGACAACGTCACCCGCCTTGACCGCTGGGAAACGGAACTCAATGAGGCGCTTCCCGGCGACGTGCGCGACACCACCACCCCGGCCAGCATGGCCACCACCCTGCGCAAGCTGCTAACCACCCCCTCTCTGAGCGCCCGTTCGCAGCAGCAGCTGCTGCAGTGGATGGTGGACGACCGGGTGGCCGGCCCGTTGATCCGCGCCGTGCTGCCGGCGGGCTGGTTTATCGCCGATAAAACCGGGGCCGGTGAGCGGGGCTCACGCGGCATTGTCGCCCTGCTCGGCCCGGACGGCAAAGCGGAGCGTATCGTGGTGATCTATCTGCGTGATACCCCGGCGACCATGGTCGAGCGTAACCAGCAGATCGCCGGGATAGGCGCGGCGCTGATCGAGCACTGGCAGCGCTAG	MRYVRLCLISLIAALPLAVFASPQPLEQIKISEGQLAGRVGYVEMDLASGRTLAAWRASERFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPASMATTLRKLLTTPSLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRGIVALLGPDGKAERIVVIYLRDTPATMVERNQQIAGIGAALIEHWQR	MRYVRLCLISLIAALPLAVFASPQPLEQIKISEGQLAGRVGYVEMDLASGRTLAAWRASERFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPASMATTLRKLLTTPSLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRGIVALLGPDGKAERIVVIYLRDTPATMVERNQQIAGIGAALIEHWQR	100.00	gnl|BL_ORD_ID|1531|hsp_num:0	1662			0	858	
CCI165_S85_contig_2_279 # 284297 # 284671 # -1 # ID=1_279;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.501	CCI165_S85_contig_2_279	284297	284671	-	Strict	230	243.432	marA	92.74	3000263	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; penem; disinfecting agents and antiseptics	antibiotic efflux; reduced permeability to antibiotic	resistance-nodulation-cell division (RND) antibiotic efflux pump; General Bacterial Porin with reduced permeability to beta-lactams	ATGTCCAGACGTAATAATGACGCCATCACTATCCATAGTATTTTGTCGTGGATCGAGGATAACCTGGAATCGCCCCTGTCGCTGGAAAAAGTGTCTGAGCGCTCAGGTTACTCCAAGTGGCACCTGCAACGTATGTTTAAGAAAGAGACCGGCCATTCCCTCGGCCAGTACATCCGCAGCCGTAAGCTGACGGAGATTGCGCAAAAGCTCAAGCAGAGCAATGAGCCAATCCTGTACCTGGCGGAACGCTACGGTTTCGAATCGCAGCAGACCCTGACGCGAACGTTTAAAAACTATTTCGATGTTCCGCCCCACAAATATCGCATAACGAATGTACCTGGCGAATCCCGCTATCTGCATCCGCTAAATAACTGA	MSRRNNDAITIHSILSWIEDNLESPLSLEKVSERSGYSKWHLQRMFKKETGHSLGQYIRSRKLTEIAQKLKQSNEPILYLAERYGFESQQTLTRTFKNYFDVPPHKYRITNVPGESRYLHPLNN	MSRRNTDAITIHSILDWIEDNLESPLSLEKVSERSGYSKWHLQRMFKKETGHSLGQYIRSRKMTEIAQKLKESNEPILYLAERYGFESQQTLTRTFKNYFDVPPHKYRMTNMQGESRFLHPLNHYNS	97.64	gnl|BL_ORD_ID|1769|hsp_num:0	1922			0	372	tigecycline; tetracycline; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
CCI165_S85_contig_4_65 # 63059 # 64252 # 1 # ID=1_65;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.556	CCI165_S85_contig_4_65	63059	64252	+	Strict	600	652.129	Shigella flexneri acrA	84.63	3007509	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAACAAAAACAGAGGGTTAACGCCTCTGGCGGTCGTTCTGATGCTCTCAGGCAGCTTAGCGCTAACAGGATGTGACGATAAACCGGCTCAACAAGGAGCCCAGCACATGCCGGAAGTCGGTATTGTGACGCTCAAATCCGCACCTCTACAAATAACCACCGAACTGCCAGGCCGCACCAGCGCCTATCGCATTGCGGAAGTTCGTCCTCAGGTCAGTGGCATTATTTTAAAACGTAACTTCGTGGAAGGTAGCGATATCCAGGCCGGCGTTTCCCTGTATCAGATCGATCCAGCCACCTATCAGGCCAGCTATGACAGCGCCAAAGGCGACCTGGCAAAAGCCCAGGCGGCGGCAAACATGGATCAACTGACGGTCAAGCGTTATCAGAAACTGTTAGGCACTAAATATATCAGTCAACAAGACTACGATACCGCCGTCGCGACGGCGCAGCAGAGCAATGCGGCCGTGGTCGCGGCGAAAGCAGCCGTTGAAACCGCGCGCATCAATCTGGCCTACACCAAAGTCACCTCGCCGATTAGCGGTCGCATTGGTAAATCCGCGGTGACCGAAGGGGCGCTGGTGCAAAATGGTCAAACAACCGCCCTGGCAACCGTTCAGCAGTTGGATCCGATCTATGTCGACGTCACCCAGTCGAGCAATGATTTCCTGCGCCTGAAACAGGAGCTGGCCGATGGCCGTCTGAAACAGGAAAACGGGAAAGCGAAAGTGGAGCTGGTGACTAACGACGGTCTTAAGTATCCGCAGGCTGGCACGCTGGAATTCTCGGATGTCACCGTCGATCAGACCACCGGCTCTATCACGCTGCGCGCTATTTTCCCTAACCCGGATCACACCCTGCTACCGGGGATGTTTGTCCGTGCCCGTCTGGAAGAAGGGGTTAACCCTGACGCCCTGCTGGTGCCGCAACAGGGTGTCACCCGTACGCCGCGCGGCGATGCCAGCGTCATGGTAGTGGGTGAAGGCGATAAGGTCGAAGTCCGCCAGGTCACTGCTTCTCAAGCGATTGGCGATAAATGGCTGGTCACTGACGGTCTGAAATCCGGCGATCGCGTTATCGTCACTGGCCTGCAAAAAATCAAACCAGGCGTGCAGGTAAAAGCGCAGGAAGTAGCTTCTGATGATAAACAGCAAGCCGCAGGCAACGCGCCATCAGAACAAACCAAGTCTTAA	MNKNRGLTPLAVVLMLSGSLALTGCDDKPAQQGAQHMPEVGIVTLKSAPLQITTELPGRTSAYRIAEVRPQVSGIILKRNFVEGSDIQAGVSLYQIDPATYQASYDSAKGDLAKAQAAANMDQLTVKRYQKLLGTKYISQQDYDTAVATAQQSNAAVVAAKAAVETARINLAYTKVTSPISGRIGKSAVTEGALVQNGQTTALATVQQLDPIYVDVTQSSNDFLRLKQELADGRLKQENGKAKVELVTNDGLKYPQAGTLEFSDVTVDQTTGSITLRAIFPNPDHTLLPGMFVRARLEEGVNPDALLVPQQGVTRTPRGDASVMVVGEGDKVEVRQVTASQAIGDKWLVTDGLKSGDRVIVTGLQKIKPGVQVKAQEVASDDKQQAAGNAPSEQTKS	MNKNRGFTPLAVVLMLSGSLALTGCDDKQAQQGGQQMPAVGVVTVKTEPLQITTELPGRTSAYRIAEVRPQVSGIILKRNFKEGSDIEAGVSLYQIDPATYQATYDSAKGDLAKAQAAANIAQLTVNRYQKLLGTQYISKQGYDQALADAQQANAAVTAAKAAVETARINLAYTKVTSPISGRIGKSNVTEGALVQNGQATVLATVQQLDPIYVDVTQSSNDFLRLKQELANGTLKQENGKAKVSLITSDGIKFPQDGTLEFSDVTVDQTTGSITLRAIFPNPDHTLLPGMFVRARLEEGLNPNAILVPQQGVTRTPRGDATVLVVGADDKVETRPIVASQAIGDKWLVTEGLKAGDRVVISGLQKVRPGVQVKAQEVTADNNQQAASGAQPEQSKS	100.00	gnl|BL_ORD_ID|4936|hsp_num:0	5965			0	1191	tigecycline; ciprofloxacin; tetracycline; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
CCI165_S85_contig_4_66 # 64275 # 67421 # 1 # ID=1_66;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.574	CCI165_S85_contig_4_66	64275	67421	+	Strict	1900	1936.0	acrB	91.13	3000216	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCCTAATTTCTTTATCGATCGCCCCATATTTGCATGGGTGATCGCCATCATCATCATGCTGGCTGGGGGATTATCGATCCTCAAATTGCCGGTGGCGCAATATCCGACGATTGCGCCGCCAGCAATTTCCATTACCGCCATGTACCCCGGTGCTGACGCCGAAACCGTGCAGAACACCGTGACTCAGGTTATCGAACAGAATATGAACGGTATCGATCACCTGATGTACATGTCCTCGAATGGCGACTCCACCGGTACGGCGACCATCACCCTGACCTTCGAATCCGGTACCGATCCGGACATCGCCCAGGTTCAGGTTCAGAACAAGCTGGCCCTGGCCACCCCTCTGCTGCCGCAAGAAGTACAGCAGCAAGGGATCAGCGTTGAGAAAGCGTCCAGCAGCTTCCTGATGGTTGTCGGCGTTATTAACACCAACGGCACCATGAACCAGGACGATATTTCGGACTACGTGGCGGCCAACATGAAGGACCCGATCAGCCGTACCAGCGGCGTCGGCGACGTTCAGCTTTTCGGTTCCCAGTACGCGATGCGTATCTGGATGGATCCGAATAAACTGAATAACTTCCAGCTCACGCCGGTGGACGTGATCAGCGCTCTGAAAGCGCAGAACGCCCAGGTAGCCGCTGGTCAGTTAGGCGGTACGCCGCCGGTGAAAGGCCAGCAGCTCAACGCGTCCATCGTCGCACAGACGCGTCTGACCAATACGGAAGAGTTTGGCAACATCCTGCTGAAGGTGAACCAGGATGGTTCCCAGGTTCGTCTGCGTGATGTCGCCAAAATTGAGCTGGGTGGCGAAAGCTATGACGTGGTGGCGAAGTATAACGGCCAGCCAGCGTCCGGTCTGGGTATTAAACTGGCTACCGGCGCGAACGCGCTGGATACCGCCAACGCGATCCGCGCTGAACTGGCGAAAATGGAGCCGTTTTTCCCGTCGGGGATGAAAATCGTTTACCCGTATGACACCACCCCGTTCGTGAAAATCTCTATTCACGAAGTGGTTAAAACGCTGGTGGAAGCGATCATCCTGGTCTTCCTGGTGATGTATCTGTTCCTGCAGAACTTCCGCGCCACGCTGATCCCGACCATCGCGGTGCCGGTGGTCCTGTTAGGGACCTTCGCGGTGCTGGCGGCGTTTGGCTTCTCGATAAATACCCTGACGATGTTCGGGATGGTGCTCGCCATCGGCCTGCTGGTGGATGACGCCATCGTGGTGGTCGAGAACGTCGAGCGCGTCATGGCCGAAGAAGGCCTGCCGCCGAAAGAAGCGACGCGTAAATCGATGGGGCAGATTCAGGGCGCGCTGGTAGGTATCGCCATGGTGCTGTCGGCGGTATTTATCCCGATGGCATTCTTCGGCGGTTCAACCGGCGCCATCTATCGCCAGTTCTCCATCACCATTGTTTCCGCAATGGCGCTATCGGTACTGGTCGCGCTGATCCTGACGCCGGCGCTGTGCGCCACGATGCTGAAGCCTATCCAGAAAGGCAGCCACGGCGCGACCACCGGTTTCTTCGGCTGGTTTAACCGCATGTTCGATAAGAGCACGCACCATTACACCGACAGCGTAGGCAACATTCTGCGCAGCACCGGTCGCTATCTGGTGCTGTATCTGATCATCGTGGTGGGCATGGCGTGGCTGTTCGTTCGTCTGCCGAGCTCGTTCCTGCCGGACGAAGACCAGGGGGTATTCCTGAGTATGGCCCAGCTGCCTGCCGGCGCCACCCAGGAGCGCACGCAGAAAGTGCTGGATGAGATGACGAATTACTATCTCACCAAAGAGAAGGACAACGTGGAATCCGTGTTTGCGGTTAACGGCTTCGGCTTCGCCGGCCGCGGCCAGAACACCGGTATCGCGTTCGTCTCGCTGAAAGACTGGAGCCAACGTCCGGGCGAAGAAAACAAAGTTGAAGCGATCACCGGTCGGGCGATGGGCTACTTCTCGCAGATTAAAGACGCGATGGTCTTCGCCTTTAACCTGCCGGCTATCGTTGAACTGGGTACCGCGACCGGCTTTGACTTCCAGCTGATTGATCAGGGCGGCCTGGGACACGAAAAACTGACCCAGGCACGTAATCAGCTGTTTGGCATGGTGGCGCAGCATCCTGACGTGCTGACCGGCGTGCGTCCTAACGGTCTGGAAGATACACCGCAGTTCAAAGTCGATATCGATCAGGAAAAAGCCCAGGCGCTGGGCGTCTCCATCAGCGACATTAACACCACGCTAGGCGCTGCCTGGGGCGGAAGCTATGTCAACGACTTTATCGACCGCGGCCGCGTGAAGAAAGTGTACATCATGTCCGAAGCGAAATACCGTATGCTGCCTGAGGACATCGGCAAGTGGTATGTTCGCGGCAGTGATGGCCAGATGGTGCCGTTCTCCGCCTTCTCCACCTCGCGTTGGGAATACGGTTCGCCGCGTCTGGAACGCTACAACGGTCTGCCATCGATGGAAATTCTTGGCCAGGCAGCGCCAGGCAAGAGTACCGGTGAGGCGATGAGCCTGATGGAAGAGCTGGCGGGTAAACTGCCGTCGGGTATCGGCTACGACTGGACCGGGATGTCTTATCAGGAGCGGCTGTCCGGTAACCAGGCCCCTGCCCTGTATGCCATCTCGCTGATTGTCGTCTTCCTGTGTCTGGCAGCGCTGTATGAGAGCTGGTCGATTCCGTTCTCGGTCATGCTGGTCGTACCGTTAGGTGTGGTCGGCGCGCTGTTAGCCGCCACCCTCCGCGGTTTAACCAATGACGTTTACTTCCAGGTTGGCCTGTTGACCACCATCGGCCTGTCGGCGAAAAACGCGATACTGATCGTTGAATTCGCCAAAGACCTGATGGAGAAAGAGGGCAAAGGGCTGATTGAGGCGACGCTTGAAGCGGTGCGTATGCGTCTGCGTCCGATCCTGATGACCTCCCTGGCGTTTATCCTTGGGGTTATGCCGCTGGTTATCAGCTCCGGTGCTGGCTCCGGTGCGCAGAACGCCGTCGGTACAGGCGTAATGGGCGGGATGGTGACCGCGACGATCCTGGCTATCTTCTTCGTGCCGGTGTTCTTTGTGGTGGTTCGTCGCCGCTTTAGTAAGAAAACGGAAGATATTGAGCACAGCCATCAGGTTGAGCATCATTAA	MPNFFIDRPIFAWVIAIIIMLAGGLSILKLPVAQYPTIAPPAISITAMYPGADAETVQNTVTQVIEQNMNGIDHLMYMSSNGDSTGTATITLTFESGTDPDIAQVQVQNKLALATPLLPQEVQQQGISVEKASSSFLMVVGVINTNGTMNQDDISDYVAANMKDPISRTSGVGDVQLFGSQYAMRIWMDPNKLNNFQLTPVDVISALKAQNAQVAAGQLGGTPPVKGQQLNASIVAQTRLTNTEEFGNILLKVNQDGSQVRLRDVAKIELGGESYDVVAKYNGQPASGLGIKLATGANALDTANAIRAELAKMEPFFPSGMKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQNFRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVMAEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMALSVLVALILTPALCATMLKPIQKGSHGATTGFFGWFNRMFDKSTHHYTDSVGNILRSTGRYLVLYLIIVVGMAWLFVRLPSSFLPDEDQGVFLSMAQLPAGATQERTQKVLDEMTNYYLTKEKDNVESVFAVNGFGFAGRGQNTGIAFVSLKDWSQRPGEENKVEAITGRAMGYFSQIKDAMVFAFNLPAIVELGTATGFDFQLIDQGGLGHEKLTQARNQLFGMVAQHPDVLTGVRPNGLEDTPQFKVDIDQEKAQALGVSISDINTTLGAAWGGSYVNDFIDRGRVKKVYIMSEAKYRMLPEDIGKWYVRGSDGQMVPFSAFSTSRWEYGSPRLERYNGLPSMEILGQAAPGKSTGEAMSLMEELAGKLPSGIGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFSVMLVVPLGVVGALLAATLRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMEKEGKGLIEATLEAVRMRLRPILMTSLAFILGVMPLVISSGAGSGAQNAVGTGVMGGMVTATILAIFFVPVFFVVVRRRFSKKTEDIEHSHQVEHH	MPNFFIDRPIFAWVIAIIIMLAGGLAILKLPVAQYPTIAPPAVTISASYPGADAKTVQDTVTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQEVQQQGVSVEKSSSSFLMVVGVINTDGTMTQEDISDYVAANMKDAISRTSGVGDVQLFGSQYAMRIWMNPNELNKFQLTPVDVITAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRLTSTEEFGKILLKVNQDGSRVLLRDVAKIELGGENYDIIAEFNGQPASGLGIKLATGANALDTAAAIRAELAKMEPFFPSGLKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQNFRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVMAEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGSTGAIYRQFSITIVSAMALSVLVALILTPALCATMLKPIAKGDHGEGKKGFFGWFNRMFEKSTHHYTDSVGGILRSTGRYLVLYLIIVVGMAYLFVRLPSSFLPDEDQGVFMTMVQLPAGATQERTQKVLNEVTHYYLTKEKNNVESVFAVNGFGFAGRGQNTGIAFVSLKDWADRPGEENKVEAITMRATRAFSQIKDAMVFAFNLPAIVELGTATGFDFELIDQAGLGHEKLTQARNQLLAEAAKHPDMLTSVRPNGLEDTPQFKIDIDQEKAQALGVSINDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAKYRMLPDDIGDWYVRAADGQMVPFSAFSSSRWEYGSPRLERYNGLPSMEILGQAAPGKSTGEAMELMEQLASKLPTGVGYDWTGMSYQERLSGNQAPSLYAISLIVVFLCLAALYESWSIPFSVMLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGLIEATLDAVRMRLRPILMTSLAFILGVMPLVISTGAGSGAQNAVGTGVMGGMVTATVLAIFFVPVFFVVVRRRFSRKNEDIEHSHTVDHH	99.90	gnl|BL_ORD_ID|1009|hsp_num:0	1104			0	3147	tigecycline; acriflavine; tetracycline; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
CCI165_S85_contig_4_187 # 188121 # 189218 # 1 # ID=1_187;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.593	CCI165_S85_contig_4_187	188121	189218	+	Strict	250	262.307	vanG	38.94	3002909	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; Van ligase	ATGGCAAAGATGAGGGTTGGGATCGTTTTTGGCGGTAAGTCGGCAGAGCATGAAGTGTCGCTGCAGTCAGCGAAGAATATCGTGGAAGCGATTGATAAATCACGCTTCGATGTGGTTCTGTTGGGGATTGATAAACAGGGGCTATGGCACATCAACGACGCCGGCAACTACCTGCTCAACGCTCAGGATCCTGCCCGCATCGCCCTGCGCCCTTCAACGGTGACCCTGGCGCAGATCCCGGGCCGCGAGGCGCAGCAACTGATTAACGCCGAAAGCGGCCAGCCGCTGGCGGCCATCGATGTAATTTTCCCCATCGTCCACGGCACGCTGGGCGAAGACGGTTCCCTGCAGGGGATGCTGCGCATGGCCAATCTGCCTTTCGTCGGATCCGATGTGCTGGGCTCTGCGGCCTGTATGGACAAAGATGTGACCAAACGCCTGCTGCGCGACGCCGGTCTCGCCGTCGCACCGTTTATCACCCTAACCCGCGCCAACCGCGCGCAGTTCAGCTTTGCCGATGTCGAAGCGAAGCTGGGCCTGCCGCTGTTCGTTAAGCCGGCCAACCAGGGATCGTCGGTTGGCGTCAGCAAAGTTAAAAACGAAGAGCAGTACCATCAGGCGGTGGCCCTGGCCTTTGAATTTGACCATAAAGTGGTGGTGGAGCAAGGCATTAAAGGGCGGGAAATTGAGTGTGCGGTGCTGGGTAACGACCATCCGCAAGCCAGCACCTGCGGTGAAATTGTCCTCAACAGCGAGTTTTACGCTTACGACACCAAGTATATCGACGACCAGGGCGCGAAGGTGGTGGTCCCGGCCGCCATCGCCCCGGAGATCAACGACAAGATCCGCGCTATCGCGGTGCAGGCTTACCAGACCCTGGGCTGCAGCGGCATGGCCCGCGTCGACGTCTTCCTCACCGCCGACAACGAGGTGGTGATCAACGAGATCAACACCCTGCCGGGCTTCACTAATATCAGTATGTATCCGAAGCTGTGGCAGGCCAGCGGCCTCGATTACACCAGTCTGATCACCCGCCTGATTGAGCTGGCGCTGGAGCGCCATGCCGCGGACCGGGCGCTGAAAACCTCCATGAACTAA	MAKMRVGIVFGGKSAEHEVSLQSAKNIVEAIDKSRFDVVLLGIDKQGLWHINDAGNYLLNAQDPARIALRPSTVTLAQIPGREAQQLINAESGQPLAAIDVIFPIVHGTLGEDGSLQGMLRMANLPFVGSDVLGSAACMDKDVTKRLLRDAGLAVAPFITLTRANRAQFSFADVEAKLGLPLFVKPANQGSSVGVSKVKNEEQYHQAVALAFEFDHKVVVEQGIKGREIECAVLGNDHPQASTCGEIVLNSEFYAYDTKYIDDQGAKVVVPAAIAPEINDKIRAIAVQAYQTLGCSGMARVDVFLTADNEVVINEINTLPGFTNISMYPKLWQASGLDYTSLITRLIELALERHAADRALKTSMN	MQNKKIAVIFGGNSTEYEVSLQSASAVFENINTNKFDIIPIGITRSGEWYHYTGEKEKILNNTWFEDSKNLCPVVVSQNRSVKGFLEIASDKYRIIKVDLVFPVLHGKNGEDGTLQGIFELAGIPVVGCDTLSSALCMDKDRAHKLVSLAGISVPKSVTFKRFNEEAAMKEIEANLTYPLFIKPVRAGSSFGITKVIEKQELDAAIELAFEHDTEVIVEETINGFEVGCAVLGIDELIVGRVDEIELSSGFFDYTEKYTLKSSKIYMPARIDAEAEKRIQEAAVTIYKALGCSGFSRVDMFYTPSGEIVFNEVNTIPGFTSHSRYPNMMKGIGLSFSQMLDKLIGLYVE	104.58	gnl|BL_ORD_ID|1067|hsp_num:0	1157			0	1047	vancomycin
CCI165_S85_contig_7_124 # 135774 # 137447 # 1 # ID=1_124;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.567	CCI165_S85_contig_7_124	135774	137447	+	Strict	1000	1151.73	eptB	98.56	3005047	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGAAATATATTAGAACGATGACGCAGCAGAAGCTTAGTTTTTGGCTGGCGCTGTACATCGGCTGGTTTATGAACGTCGCCGTTTTTTTTCGGCGTTTCGATGGTTATGCTCAAGAGTTCACTGTCTGGAAAGGGCTTTCCGGTGTCGTTGAACTGGTGGCCACGGTCTTTGTCACCTTCTTCCTGTTACGTCTTCTGTCGCTGTTCGGTCGCCGTATCTGGCGCATTCTGGCGACGCTGATTGTTCTGTTTTCCGCCGCCGCCAGTTACTACATGACGTTCCTTAACGTGGTGATTGGCTACGGGATTATCGCCTCGGTGATGACCACCGATATCGACCTGTCGAAAGAGGTCATCGGCTGGCATCTGATCCTCTGGCTGGCGGCAGTGAGCGCGCCGCCACTGCTGTTTATCTGGAGCAACCGCTGCCGCCATACGCTGCTGCGCCAACTGCGTACCCCGGGCCAGCGGGTTAAAAACGTGCTGATCGTGGTGTTGGCCGGCCTCATCGTCTGGGGACCTATCCGCCTGCTTGAGCTGCGCCAACACGATGTCGAGCGCCATTCGGAAGTGGATATGCCGAGCTACGGCGGGGTGATCGCCAACTCCTACCTGCCGTCGAACTGGCTGTCGGCGCTGGGGCTGTACGCCTGGGCGCAGGTGGATGAATCCTCAGATAACAAATCGCTGATTAACCCGGCGAAGAAATTTACCTACGTCGCCCCGGAAGGGCTCGATGACACCTACGTGGTGTTTATCATTGGCGAAACCACCCGCTGGGATCATATGGGCATCCTTGGCTATAGCCGTAACACCACGCCAGAGCTGGCGAAAGAGAAGAATCTGGTCGCTTTCCGCGGCTACTCGTGCGATACCGCCACCAAGCTGTCGTTACGCTGCATGTTTGTGCGTCAGGGCGGGGCAGAGGATAACCCGCAGCGGACCCTCAAAGAGCAGAACGTCTTTGCGGTGCTTCATCAGCTGGGCTTCAGCGGCAATCTGTACGCCATGCAGAGTGAGATGTGGTTCTACAGCAACACGATGGCCAACAATATCGCCTATCGCGAGCAGATTGGCGCCGAGCCGCGCAACCGCGGCAAGAGCGTTGACGATATGCTGCTGGTGGATGAGATGAAGCGCGGTATGGAGCAGGGCAACGCCTCTGGTAAGCACCTGATCATCCTCCACACGAAAGGCTCGCACTTTAACTACACCCAACGCTATCCGCGCAGCTTCGCCCAGTGGAAGCCGGAGTGCGTCGGTGTTGATAACAAGTGCTCGAAAGCGGAGCTGATCAACTCCTACGACAACAGCGTGACCTATGTCGATCACTTTATCGTCAGCGTCCTCGACCAGCTGCGGGATAAGAAAGCGATTGTGTTCTATGCCGCCGACCACGGCGAGTCGATTAACGAGCGTGAACATCTGCACGGTACGCCGCGCAAGATGGCGCCGCCGGAACAGTTCCGTGTGCCGATGATGGTCTGGATGTCGGATAAATACCTGGAGAATCCGGATCATGCCGCTGCGTTTGCCCATCTGCAGCAGCAGGCCGCGATGAAGGTGCCGCGCCGTCACGTCGAACTGTACGACACCATTATGGGCTGCCTTGGCTATACCTCGCCGGATGGCGGGATCAACGAGAACAATAACTGGTGTCGGTGGAAAAAGTAA	MKYIRTMTQQKLSFWLALYIGWFMNVAVFFRRFDGYAQEFTVWKGLSGVVELVATVFVTFFLLRLLSLFGRRIWRILATLIVLFSAAASYYMTFLNVVIGYGIIASVMTTDIDLSKEVIGWHLILWLAAVSAPPLLFIWSNRCRHTLLRQLRTPGQRVKNVLIVVLAGLIVWGPIRLLELRQHDVERHSEVDMPSYGGVIANSYLPSNWLSALGLYAWAQVDESSDNKSLINPAKKFTYVAPEGLDDTYVVFIIGETTRWDHMGILGYSRNTTPELAKEKNLVAFRGYSCDTATKLSLRCMFVRQGGAEDNPQRTLKEQNVFAVLHQLGFSGNLYAMQSEMWFYSNTMANNIAYREQIGAEPRNRGKSVDDMLLVDEMKRGMEQGNASGKHLIILHTKGSHFNYTQRYPRSFAQWKPECVGVDNKCSKAELINSYDNSVTYVDHFIVSVLDQLRDKKAIVFYAADHGESINEREHLHGTPRKMAPPEQFRVPMMVWMSDKYLENPDHAAAFAHLQQQAAMKVPRRHVELYDTIMGCLGYTSPDGGINENNNWCRWKK	MPQRQAVFYSSFSRFACMKYIRTMTQQKLSFWLALYIGWFMNVAVFFRRFDGYAQEFTFWKGLSGVVELVATVFVTFFLLRLLSLFGRRIWRILATLIVLFSAAASYYMTFLNVVIGYGIIASVMTTDIDLSKEVIGWHLILWLVVVSAPPLLFIWSNRCRHTLLRQLRTPGQRVKNVLIVVLAGLIVWGPIRLLELRQHDVERHSEVDMPSYGGVIANSYLPSNWLSALGLYAWAQVDESSDNKSLINPAKKFTYVAPEGLDDTYVVFIIGETTRWDHMGILDYSRNTTPELEKEKNLVAFRGYLCDTATKLSLRCMFVREGGAEDNPQRTLKEQNVFAVLHQLGFSGNLYAMQSEMWFYSNTMANNIAYREQIGAEPRNRGKSVDDMLLVDEMKRGMAQGNASGKHLIILHTKGSHFNYTQRYPRSFAQWKPECVGVDNKCSKAELINSYDNSVTYVDHFIVSVLDQLRDKKAIVFYAADHGESINEREHLHGTPRKMAPPEQFRVPMMVWMSDKYLENPDHAAAFAHLQQQAAMKVPRRHVELYDTIMGCLGYTSPDGGINENNNWCRWKK	97.04	gnl|BL_ORD_ID|2784|hsp_num:0	3791			51	1722	polymyxin B; colistin A; colistin B
CCI165_S85_contig_8_48 # 44086 # 45261 # 1 # ID=1_48;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.610	CCI165_S85_contig_8_48	44086	45261	+	Strict	670	772.696	oqxA	96.93	3003922	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; glycylcycline; tetracycline antibiotic; diaminopyrimidine antibiotic; nitrofuran antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAGCCTGCAAAAAACCTGGGGAAACATTCACCTGACCGCGCTCGGCGCGATGATGCTCTCCTTTCTGCTCGTCGGCTGCGACGACAGCGTCGCGCAAAACGCCGCGCCGCCCGCGCCTGCCGTCAGCGCCGCTAAGGTGTTGGTGAAGTCGATCAGTCAGTGGGATAGTTTTAACGGTCGCATTGAAGCGGTGGAGAGCGTTCAGCTCCGCCCCCGCGTCTCGGGATATATTGATAAAGTGAATTATACCGACGGCCAGGAGGTGAAAAAGGGCCAGGTGCTGTTCACGATAGACGACAGAACCTATCGCGCCGCGCTGGAGCAGGCGCAGGCGATGCTGGCGAGAGCCAAAACGCAGGCCAGTCTGGCGCAAAGCGAGGCGAACCGCACCGATAAATTAGTTCATACCAACCTCGTCTCCCGTGAAGAGTGGGAGCAGCGCCGGTCAGCCGCGGTTCAGGCCCAGGCCGATATTCGCGCCGCGCAGGCGGCGGTGGATGCCGCGCAGCTTAACCTCGACTTCACCAAAGTGACTGCCCCTATCGACGGCCGCGCCAGCCGGGCGCTGATCACCAGCGGCAACCTGGTCACGGCGGGCGACACCGCCAGCGTGCTCACCACCCTGGTCTCGCAGAAGACGGTGTACGTCTACTTTGACGTCGACGAGTCAACCTACCTGCACTATCAGAATCTCGCCCGCCGCGGGCAAAGCGCCTCCAGCGATAATCAGGCGCTCCCGGTGGAGATTGGCCTGGTTGGCGAGGAGGGCTACCCCCATCAGGGCAAAGTGGATTTTCTCGATAATCAGTTAACGCCGAGCACCGGCACCATCCGCATGCGCGCCCTGCTGGATAACTCGCAGCGGCTGTTCACGCCGGGGCTGTTTGCCCGCGTGCGTCTGCCGGGCAGCGCGGCGTTCCAGGCTACGCTTATCGACGACAAAGCGGTGCTCACCGATCAGGACCGCAAATATGTCTATATCGTTGATAAAGATGGCAAAGCGCAGCGACGTGATATCACGCCGGGGCGGCTGGTCGATGGTTTACGCATCGTGAAGCAGGGTCTGAAGCCTGGGGATAGCGTCATCGTCGACGGCTTACAAAAAGTGTTTATGCCAGGTATGGCGGTTAACGCCAAAACCGTTGCCATGACCCCCAGCGCCGCCCTCAACTGA	MSLQKTWGNIHLTALGAMMLSFLLVGCDDSVAQNAAPPAPAVSAAKVLVKSISQWDSFNGRIEAVESVQLRPRVSGYIDKVNYTDGQEVKKGQVLFTIDDRTYRAALEQAQAMLARAKTQASLAQSEANRTDKLVHTNLVSREEWEQRRSAAVQAQADIRAAQAAVDAAQLNLDFTKVTAPIDGRASRALITSGNLVTAGDTASVLTTLVSQKTVYVYFDVDESTYLHYQNLARRGQSASSDNQALPVEIGLVGEEGYPHQGKVDFLDNQLTPSTGTIRMRALLDNSQRLFTPGLFARVRLPGSAAFQATLIDDKAVLTDQDRKYVYIVDKDGKAQRRDITPGRLVDGLRIVKQGLKPGDSVIVDGLQKVFMPGMAVNAKTVAMTPSAALN	MSLQKTWGNIHLTALGAMMLSFLLVGCDDSVAQNAAPPAPTVSAAKVLVKSISQWDSFNGRIEAVESVQLRPRVSGYIDKVNYTDGQEVKKGQVLFTIDDRTYRAALEQAQAALARAKTQASLAQSEANRTDKLVHTNLVSREEWEQRRSAAVQAQADIRAAQAAVDAAQLNLDFTKVTAPIDGRASRALITSGNLVTAGDTASVLTTLVSQKTVYVYFDVDESTYLHYQNLARRGQGASSDNQALPVEIGLVGEEGYPHQGKVDFLDNQLTPSTGTIRMRALLDNSQRLFTPGLFARVRLPGSAEFKATLIDDKAVLTDQDRKYVYIVDKDGKAQRRDITPGRLADGLRIVQKGLNPGDSVIVDGLQKVFMPGMPVNAKTVAMTSSATLN	100.00	gnl|BL_ORD_ID|2150|hsp_num:0	2399			0	1173	tigecycline; ciprofloxacin; nitrofurantoin; trimethoprim
CCI165_S85_contig_8_49 # 45285 # 48437 # 1 # ID=1_49;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.610	CCI165_S85_contig_8_49	45285	48437	+	Strict	2000	2095.47	oqxB	98.86	3003923	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; glycylcycline; tetracycline antibiotic; diaminopyrimidine antibiotic; nitrofuran antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGACTTTTCCCGCTTTTTTATCGACAGGCCCATTTTCGCCGCGGTGCTGTCGATTTTAATTTTTATCACCGGGTTAATCGCCATCCCGCTGCTGCCGGTGAGCGAATATCCTGACGTCGTGCCGCCCAGCGTGCAGGTGCGCGCGGAGTATCCCGGCGCCAACCCGAAAGTGATCGCCGAGACCGTGGCGACGCCGCTGGAGGAAGCGATCAACGGCGTTGAAAACATGATGTACATGAAATCGGTCGCCGGCTCCGACGGCGTGCTGGTGACCACCGTGACCTTCCGCCCGGGTACCGACCCGGATCAGGCGCAGGTTCAGGTGCAGAACCGGGTCGCGCAGGCCGAGGCGCGTCTGCCGGAGGACGTGCGCCGTCTGGGGATCACCACCCAGAAACAGTCCCCGACGCTGACCCTGGTGGTACATCTGTTTTCGCCTAACGGTAAGTACGACTCGCTGTATATGCGCAACTACGCCACGCTGAAGGTGAAGGATGAGCTGGCGCGCTTGCCCGGCGTCGGCCAGATCCAGATATTTGGCTCCGGCGAATACGCGATGCGCGTCTGGCTGGATCCCAACAAGGTGGCCGCCCGCGGTCTGACGGCCTCGGATGTGGTGACGGCGATGCAGGAGCAAAACGTCCAGGTCTCCGCCGGTCAGCTTGGCGCCGAGCCGCTGCCGCAGGAGAGCGACTTCCTGATCTCGATTAACGCCCAGGGCCGTCTGCATACCGAAGAAGAGTTTGGCAATATCATTCTGAAAACGGCGCAGGACGGCTCGCTGGTCCGCCTGCGCGACGTGGCGCGCATCGAGATGGGTTCTGGTAGCTATGCGCTGCGCTCCCAGCTCAACAATAAGGATGCGGTCGGGATCGGTATCTTCCAGTCCCCGGGGGCTAACGCCATCGATTTATCGAACGCCGTGCGTGCCAAAATGGCCGAGCTGGCCACCCGCTTCCCGGAAGATATGAAGTGGGCGGCGCCGTACGACCCGACGGTTTTCGTCCGCGACTCCATCCGCGCGGTGGTGCAGACGCTGCTGGAGGCGGTAGTGCTGGTGGTACTGGTGGTGATCCTGTTCCTGCAGACCTGGCGCGCATCGATTATCCCGCTGATCGCGGTGCCGGTATCGGTGGTCGGTACCTTCAGCATTCTCTATCTGCTGGGCTTCTCGCTGAATACCCTGAGCCTGTTCGGGCTGGTACTGGCGATTGGTATCGTGGTGGATGACGCCATCGTGGTGGTGGAAAACGTCGAGCGCAATATCGAAGAGGGGCTTGCGCCGCTTGCCGCGGCGCATCAGGCGATGCGAGAGGTCTCCGGGCCGATTATCGCTATTGCGCTGGTGCTGTGCGCGGTGTTCGTGCCAATGGCGTTTCTCTCAGGCGTTACCGGTCAGTTCTACAAGCAGTTTGCGGTGACCATCGCCATCTCCACGGTGATCTCGGCCATCAACTCGCTGACGCTCTCCCCGGCGCTGGCGGCCCTGCTGTTAAAGCCGCACGGCGCGAAAAAAGATCTCCCTACCCGGCTGATCGATCGTCTGTTTGGCTGGATTTTCCGTCCGTTTAACCGCTTTTTCCTGCGCAGCTCAAACGGCTATCAGGGGCTGGTGAGCAAAACCCTCGGACGCCGTGGCGCGGTGTTTGTGGTGTACCTGCTGCTGCTCTGCGCCGCAGGGGTGATGTTTAAAGTCGTTCCCGGCGGATTTATTCCCACCCAGGACAAACTGTACCTGATTGGCGGCGTGAAGATGCCGGAAGGTTCGTCGCTGGCGCGCACCGATGCGGTGATCCGCAAAATGAGCGAGATCGGGATGAATACCGAAGGGGTCGATTATGCGGTCGCCTTCCCCGGTCTTAACGCGCTGCAGTTCACCAACACGCCGAATACCGGGACGGTCTTTTTTGGCCTGAAACCGTTCGACCAGCGCAAACACTCGGCGGCGGAAATCAATGCGGAAATCAACGCTAAAATCGCGCAAATCCAGCAGGGCTTTGGCTTCTCCATCCTGCCGCCGCCGATTTTAGGACTGGGTCAGGGCTCCGGCTACTCCCTTTACATCCAGGATCGCGGTGGGCTGGGCTATGGCGCGCTGCAAAGCGCGGTGAATGCGATGTCCGGGACGATTATGCAGACGCCGGGGATGCACTTCCCGATCTCGACCTACCAGGCTAACGTGCCGCAGCTGGACGTGCAGGTCGATCGCGATAAGGCGAAAGCGCAGGGGGTATCGCTGACCGATCTGTTCGGCACGCTGCAGACCTATCTCGGCTCGTCTTATGTCAATGACTTTAACCAGTTCGGGCGTACCTGGCGCGTGATGGCCCAGGCTGACGGACCATACCGCGAGAGCGTGGAAGATATCGCCAATCTGCGCACCCGCAATAATCAGGGCGAAATGGTGCCGATCGGCAGTATGGTGAATATCAGTACCACCTACGGGCCGGATCCGGTGATCCGCTACAACGGTTATCCGGCGGCGGACCTGATTGGCGATGCCGATCCGCGCGTTCTCTCCTCCTCGCAGGCGATGACGCTGCTGGACGCCATGTCTAAACAGGTGCTGCCGAATGGGATGAATATTGAATGGACGGATCTCAGCTTCCAGCAGGCCACTCAGGGCAACACGGCGCTGATCGTCTTCCCGGTGGCGGTGCTGCTGGCGTTCCTCGTGCTGGCAGCGCTGTATGAAAGCTGGACCCTGCCGCTGGCGGTGATCCTTATCGTGCCGATGACGATGCTCTCCGCGCTATTTGGCGTCTGGCTGACCGGGGGCGATAACAACGTCTTCGTGCAGGTGGGGCTGGTGGTCCTGATGGGCCTGGCCTGTAAAAACGCCATTCTGATCGTCGAGTTTGCCCGCGAGCTGGAGATTCAGGGCAAAGGCATCATGGAGGCCGCGCTGGAGGCGTGCCGCCTGCGTCTGCGCCCGATTGTGATGACCTCCATCGCCTTTATCGCCGGGACCATTCCGCTGATCCTCGGCCACGGCGCAGGAGCGGAAGTTCGCGGCGTCACCGGGATCACGGTGTTCTCCGGGATGCTGGGGGTGACGCTGTTCGGTCTGTTCCTGACACCGGTGTTTTACGTGACGCTACGGAAACTGGTGACCCGCAGTAAGCCGGTCCAGGAGGATCTGCCCGCCTAG	MDFSRFFIDRPIFAAVLSILIFITGLIAIPLLPVSEYPDVVPPSVQVRAEYPGANPKVIAETVATPLEEAINGVENMMYMKSVAGSDGVLVTTVTFRPGTDPDQAQVQVQNRVAQAEARLPEDVRRLGITTQKQSPTLTLVVHLFSPNGKYDSLYMRNYATLKVKDELARLPGVGQIQIFGSGEYAMRVWLDPNKVAARGLTASDVVTAMQEQNVQVSAGQLGAEPLPQESDFLISINAQGRLHTEEEFGNIILKTAQDGSLVRLRDVARIEMGSGSYALRSQLNNKDAVGIGIFQSPGANAIDLSNAVRAKMAELATRFPEDMKWAAPYDPTVFVRDSIRAVVQTLLEAVVLVVLVVILFLQTWRASIIPLIAVPVSVVGTFSILYLLGFSLNTLSLFGLVLAIGIVVDDAIVVVENVERNIEEGLAPLAAAHQAMREVSGPIIAIALVLCAVFVPMAFLSGVTGQFYKQFAVTIAISTVISAINSLTLSPALAALLLKPHGAKKDLPTRLIDRLFGWIFRPFNRFFLRSSNGYQGLVSKTLGRRGAVFVVYLLLLCAAGVMFKVVPGGFIPTQDKLYLIGGVKMPEGSSLARTDAVIRKMSEIGMNTEGVDYAVAFPGLNALQFTNTPNTGTVFFGLKPFDQRKHSAAEINAEINAKIAQIQQGFGFSILPPPILGLGQGSGYSLYIQDRGGLGYGALQSAVNAMSGTIMQTPGMHFPISTYQANVPQLDVQVDRDKAKAQGVSLTDLFGTLQTYLGSSYVNDFNQFGRTWRVMAQADGPYRESVEDIANLRTRNNQGEMVPIGSMVNISTTYGPDPVIRYNGYPAADLIGDADPRVLSSSQAMTLLDAMSKQVLPNGMNIEWTDLSFQQATQGNTALIVFPVAVLLAFLVLAALYESWTLPLAVILIVPMTMLSALFGVWLTGGDNNVFVQVGLVVLMGLACKNAILIVEFARELEIQGKGIMEAALEACRLRLRPIVMTSIAFIAGTIPLILGHGAGAEVRGVTGITVFSGMLGVTLFGLFLTPVFYVTLRKLVTRSKPVQEDLPA	MDFSRFFIDRPIFAAVLSILIFITGLIAIPLLPVSEYPDVVPPSVQVRAEYPGANPKVIAETVATPLEEAINGVENMMYMKSVAGSDGVLVTTVTFRPGTDPDQAQVQVQNRVAQAEARLPEDVRRLGITTQKQSPTLTLVVHLFSPGGKYDSLYMRNYATLKVKDELARLPGVGQIQIFGSGEYAMRVWLDPNKVAARGLTASDVVTAMQEQNVQVSAGQLGAEPLPQESDFLISINAQGRLHTEEEFGNIILKTAQDGSLVRLRDVARIEMGSGSYALRSQLNNKDAVGIGIFQSPGANAIDLSNAVRAKMAELATRFPEDMQWAAPYDPTVFVRDSIRAVVQTLLEAVVLVVLVVILFLQTWRASIIPLIAVPVSVVGTFSILYLLGFSLNTLSLFGLVLAIGIVVDDAIVVVENVERNIEEGLAPLAAAHQAMREVSGPIIAIALVLCAVFVPMAFLSGVTGQFYKQFAVTIAISTVISAINSLTLSPALAALLLKPHGAKKDLPTRLIDRLFGWIFRPFNRFFLRSSNGYQGLVGKTLGRRGAVFAVYLLLLCAAGVMFKVVPGGFIPTQDKLYLIGGVKMPEGSSLARTDAVIRKMSEIGMNTEGVDYAVAFPGLNALQFTNTPNTGTVFFGLKPFDQRKHTAAEINAEINAKIAQIQQGFGFSILPPPILGLGQGSGYSLYIQDRGGLGYGALQSAVNAMSGAIMQTPGMHFPISTYQANVPQLDVQVDRDKAKAQGVSLTDLFGTLQTYLGSSYVNDFNQFGRTWRVMAQADGPYRESVEDIANLRTRNNQGEMVPIGSMVNISTTYGPDPVIRYNGYPAADLIGDADPRVLSSSQAMTHLEELSKQILPNGMNIEWTDLSFQQATQGNTALIVFPVAVLLAFLVLAALYESWTLPLAVILIVPMTMLSALFGVWLTGGDNNVFVQVGLVVLMGLACKNAILIVEFARELEIQGKGIMEAALEACRLRLRPIVMTSIAFIAGTIPLILGHGAGAEVRGVTGITVFSGMLGVTLFGLFLTPVFYVTLRKLVTRRKPVQEDLPA	100.00	gnl|BL_ORD_ID|2151|hsp_num:0	2400			0	3150	tigecycline; ciprofloxacin; nitrofurantoin; trimethoprim
CCI165_S85_contig_8_114 # 111647 # 112177 # 1 # ID=1_114;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.525	CCI165_S85_contig_8_114	111647	112177	+	Strict	280	338.961	emrR	92.57	3000516	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGATAGTTCGTTTACTCCCATTGAGCAAATGCTCAAGTTCCGCGCCAGCCGCCATGAAGATTTCCCGTTCCAGGAGATTCTGTTAACTCGTCTTTGCATGCATATGCAAGGTAAGCTGCTGGAAAATCGCAATAAAATGCTCAAAGCGCAGGGAATTAACGAGACATTATTTATGGCGCTGATTACGCTGGAGTCGCAGGAAAACCACAGCATTCAGCCGTCCGAGCTGAGCTGTGCGCTGGGCTCGTCGCGTACCAACGCCACCCGTATCGCTGATGAACTGGAAAAACGCGGCTGGATTGAACGCCGCGAGAGCGATAACGATCGTCGCTGTCTGCATCTGCAGCTGACCGAAAAGGGCCATCAGTTTTTGCGTGAAGTCCTGCCGCCGCAGCATAACTGCCTGCATCAGCTGTGGTCTTCACTCAGCACCAGCGAAAAAGATCAGCTCGAACATATTACCCGCAAACTCCTGAGCCGCCTTGACCAGATGGAAGAAGAAGGCGTGCTGGCGGACTCTCTACGCTAA	MDSSFTPIEQMLKFRASRHEDFPFQEILLTRLCMHMQGKLLENRNKMLKAQGINETLFMALITLESQENHSIQPSELSCALGSSRTNATRIADELEKRGWIERRESDNDRRCLHLQLTEKGHQFLREVLPPQHNCLHQLWSSLSTSEKDQLEHITRKLLSRLDQMEEEGVLADSLR	MDSSFTPIEQMLKFRASRHEDFPYQEILLTRLCMHMQSKLLENRNKMLKAQGINETLFMALITLESQENHSIQPSELSCALGSSRTNATRIADELEKRGWIERRESDNDRRCLHLQLTEKGHEFLREVLPPQHNCLHQLWSALSTTEKDQLEQITRKLLSRLDQMEQDGVVLEAMS	100.00	gnl|BL_ORD_ID|1223|hsp_num:0	1330			0	525	nalidixic acid
CCI165_S85_contig_8_115 # 112303 # 113475 # 1 # ID=1_115;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.603	CCI165_S85_contig_8_115	112303	113475	+	Strict	700	784.637	Klebsiella pneumoniae KpnG	98.97	3004588	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; penam; peptide antibiotic; penem	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAGCGCAAATGCGGAGAGCCAAACCCCGCAGCAACCAGGCAGCAAAAAAGGGAAGCGTAAAGGCGCCCTTCTGTTGCTGACATTGCTCTTCATTATTATTGCCGTGGCATATGGGATTTACTGGTTTCTGGTACTGCGTCACTACGAAGAGACCGACGATGCCTACGTGGCAGGGAACCAGGTACAAATTATGGCCCAGGTCTCGGGCAGCGTGACCAAAGTCTGGGCTGACAACACGGACTACGTGCAGAAAGGCGATCCGCTGGTCACCCTCGATCAGACCGATGCCCAACAGGCGTTTGAGAAAGCCAAGACGCAGCTGGCCGCCAGCGTGCGTCAAACCCGTCAGCAGATGATCAACAGCAAGCAGCTGCAGGCGAATATTGACGTCAAAAAGACCGCCCTCGCCCAGGCGCAGGCTGACCTGAACCGCCGTATCCCGCTGGGCGCGGCGAACCTCATCGGCCGCGAAGAGCTGCAGCACGCCCGCGACACCGTCGCCAGCGCGCAGGCCGAGCTTGACGTGGCCATCCAGCAGTACAACGCCAACCAGGCGATCGTGCTGGGTACCAAACTCGAACAGCAGCCGGCGGTGCTGCAGGCGGCGACCGAAGTGCGTAACGCCTGGCTGGCCCTGCAGCGTACGCAGATCGTCAGCCCGATTAGCGGCTACGTTTCCCGTCGCTCGGTACAGCCTGGCGCGCAGATCGGCACCACCACGCCGCTGATGGCGGTGGTTCCGGCAACTAACCTGTGGATCGACGCTAACTTTAAAGAGACCCAGCTGGCGCATATGCGCATCGGCCAGCCGGCCACGGTGATCAGCGACATCTATGGCGATGACGTGAAATACACCGGCAAGGTGGTTGGTCTGGATATGGGGACCGGGAGCGCCTTCTCCCTGCTGCCGGCGCAGAACGCCACCGGTAACTGGATCAAAGTGGTACAGCGTCTGCCGGTCCGCATCGAACTGGATGAAAAACAGCTGGCGGAACACCCGCTGCGCATCGGCCTCTCGACGTTGGTAGAAGTTAACACCACCGATCGCGATGGCGAAATGCTGGCAAGCCAGGTGCGGAGCTCCCCGGTCTACGAGAGCAACGCCCGCGAAATCGCTCTCGATCCGGTCAATAAGCTGATAGACGAGATCATTCAGGCCAACGCCGGATAA	MSANAESQTPQQPGSKKGKRKGALLLLTLLFIIIAVAYGIYWFLVLRHYEETDDAYVAGNQVQIMAQVSGSVTKVWADNTDYVQKGDPLVTLDQTDAQQAFEKAKTQLAASVRQTRQQMINSKQLQANIDVKKTALAQAQADLNRRIPLGAANLIGREELQHARDTVASAQAELDVAIQQYNANQAIVLGTKLEQQPAVLQAATEVRNAWLALQRTQIVSPISGYVSRRSVQPGAQIGTTTPLMAVVPATNLWIDANFKETQLAHMRIGQPATVISDIYGDDVKYTGKVVGLDMGTGSAFSLLPAQNATGNWIKVVQRLPVRIELDEKQLAEHPLRIGLSTLVEVNTTDRDGEMLASQVRSSPVYESNAREIALDPVNKLIDEIIQANAG	MSANAESQTPQQPGSKKGKRKGALLLLTLLFIIIAVAYGIYWFLVLRHYEETDDAYVAGNQVQIMAQVAGSVTKVWADNTDYVQKGDPLVTLDRTDAQQAFEKAKTQLAASVRQTRQQMINSKQLQANIDVKKTALSQAQADLNRRIPLGAANLIGREELQHARDTVASAQAELDVAIQQYNANQAIVLGTRLEQQPAVLQAATEVRNAWLALQRTQIVSPISGYVSRRSVQPGAQIGTTTPLMAVVPATNLWIDANFKETQLAHMRIGQPATVISDIYGDDVKYTGKVVGLDMGTGSAFSLLPAQNATGNWIKVVQRLPVRIELDEKQLAEHPLRIGLSTLVEVNTTDRDGEMLASQVRSSPVYESNAREIALDPVNKLIDEIIQANAG	100.00	gnl|BL_ORD_ID|2738|hsp_num:0	3298			0	1170	erythromycin; gentamicin C; ciprofloxacin; spectinomycin; streptomycin; tobramycin; ceftazidime; ertapenem; piperacillin; azithromycin; imipenem; polymyxin B; polymyxin B1; polymyxin B2; polymyxin B3; polymyxin B4; norfloxacin; ticarcillin; gentamicin
CCI165_S85_contig_8_116 # 113491 # 115029 # 1 # ID=1_116;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=3-4bp;gc_cont=0.613	CCI165_S85_contig_8_116	113491	115029	+	Strict	700	937.947	Klebsiella pneumoniae KpnH	94.02	3004597	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; penam; peptide antibiotic; penem	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCAACAGCAAAAACCGCTGGAAGGCGCGCAGCTGGTCATCATGACCATTGCGCTGTCGCTCGCGACGTTCATGCAGGTGCTGGATTCCACTATCGCCAACGTGGCGATCCCGACCATCGCCGGTAACCTTGGCTCATCGCTGAGCCAGGGGACCTGGGTCATCACTTCGTTCGGGGTCGCTAACGCCATCTCCATTCCGATCACCGGATGGCTGGCCAAGCGCGTGGGCGAGGTGAAGCTGTTCCTGTGGTCCACCACCGCTTTCGCCATCGCCTCCTGGGCCTGCGGCGTCTCCAACAGCCTGACGATGCTGATCTTCTTCCGCGTCATTCAGGGGATTGTTGCCGGGCCGCTGATCCCGCTGTCGCAAAGTCTGTTGCTCAGCAACTATCCGCCGGCGAAACGCTCTATCGCCCTGGCGCTGTGGTCGATGACGGTGATCGTCGCTCCCATCTGCGGCCCGATCCTCGGCGGCTATATCAGCGATAACTACCACTGGGGATGGATCTTCTTTATCAACGTGCCCATTGGCGTGGCGGTGGTGCTGATGACCCTGCAGACCCTGCGCAACCGGGAAACCAAAACCGAACAGCGGCGTATCGACGGCGTCGGCCTGGCGCTGCTGATCATCGGTATCGGTAGTCTGCAGGTGATGCTGGACCGGGGCAAAGAGCTGGACTGGTTCTCCTCCAATGAAATTATCATTCTGACCATCGTGGCGGTGGTGGCGATAAGCTTCCTGATCGTCTGGGAGCTGACCGACGATAACCCGATTGTCGATCTGTCGCTGTTTAAGTCGCGCAACTTCACCATCGGCTGCCTCTGCATCAGCCTGGCCTACATGCTCTACTTCGGGGCCATCGTGCTGCTGCCGCAGCTGTTGCAGGAGGTCTACGGCTACACTGCGACCTGGGCCGGCCTGGCGTCAGCGCCGGTGGGGGTGATCCCGGTCATTCTGTCGCCGATTATCGGCCGCTTTGCGCATAAGCTCGATATGCGGCGGCTGGTCACCTTCAGCTTTATCATGTACGCCGTCTGCTTCTACTGGCGCGCCTGGACCTTCGAACCGGGGATGGACTTTGGCGCCTCGGCGTGGCCGCAGTTTATCCAGGGCTTCGCGGTGGCCTGCTTCTTCATGCCGTTGACCACCATCACCCTTTCCGGCCTGCCGCCGGAGCGGCTGGCGGCGGCGTCGAGCTTGTCGAACTTCACCCGTACCCTTGCTGGCTCCATCGGGACCTCGATCACCACCACCCTGTGGACCAACCGCGAGGCGCTGCACCATGCGCAGCTCACCGAATCGGTGACGCCGTTCAACCCCAACGCGCAGCAGATCTACGATCAGCTGCAGGGGATGGGAATGACGCAGCAACAGGCGTCCGGCTGGATAGCACAGCAGATAACCAACCAGGGGCTGATTATCTCTGCCAACGAAATCTTCTGGATCTCAGCGGCCATTTTCATCCTGCTGTTGGGACTGGTATGGTTCGCCAGACCCCCGTTCAGCGCCGGCGGCGGCGGCGGCGGCGCGCACTAA	MQQQKPLEGAQLVIMTIALSLATFMQVLDSTIANVAIPTIAGNLGSSLSQGTWVITSFGVANAISIPITGWLAKRVGEVKLFLWSTTAFAIASWACGVSNSLTMLIFFRVIQGIVAGPLIPLSQSLLLSNYPPAKRSIALALWSMTVIVAPICGPILGGYISDNYHWGWIFFINVPIGVAVVLMTLQTLRNRETKTEQRRIDGVGLALLIIGIGSLQVMLDRGKELDWFSSNEIIILTIVAVVAISFLIVWELTDDNPIVDLSLFKSRNFTIGCLCISLAYMLYFGAIVLLPQLLQEVYGYTATWAGLASAPVGVIPVILSPIIGRFAHKLDMRRLVTFSFIMYAVCFYWRAWTFEPGMDFGASAWPQFIQGFAVACFFMPLTTITLSGLPPERLAAASSLSNFTRTLAGSIGTSITTTLWTNREALHHAQLTESVTPFNPNAQQIYDQLQGMGMTQQQASGWIAQQITNQGLIISANEIFWISAAIFILLLGLVWFARPPFSAGGGGGGAH	MQQQKPLEGAQLVIMTIALSLATFMQVLDSTIANVAIPTIAGNLGSSLSQGTWVITSFGVANAISIPLTGWLAKRVGEVKLFLWSTIAFAIASWACGVSSSLNMLIFFRVIQGIVAGPLIPLSQSLLLNNYPPAKRSIALALWSMTVIVAPICGPILGGYISDNYHWGWIFFINVPIGVAVVLMTLQTLRGRETRTERRRIDAVGLALLVIGIGSLQIMLDRGKELDWFSSQEIIILTVVAVVAICFLIVWELTDDNPIVDLSLFKSRNFTIGCLCISLAYMLYFGAIVLLPQLLQEVYGYTATWAGLASAPVGIIPVILSPIIGRFAHKLDMRRLVTFSFIMYAVCFYWRAYTFEPGMDFGASAWPQFIQGFAVACFFMPLTTITLSGLPPERLAAASSLSNFTRTLAGSIGTSITTTMWTNRESMHHAQLTESVNPFNPNAQAMYSQLEGLGMTQQQASGWIAQQITNQGLIISANEIFWMSAGIFLILLGLVWFAKPPFGAGGGGGGAH	100.00	gnl|BL_ORD_ID|2739|hsp_num:0	3299			0	1506	erythromycin; gentamicin C; ciprofloxacin; spectinomycin; streptomycin; tobramycin; ceftazidime; ertapenem; piperacillin; azithromycin; imipenem; polymyxin B; polymyxin B1; polymyxin B2; polymyxin B3; polymyxin B4; norfloxacin; ticarcillin; gentamicin
CCI165_S85_contig_8_124 # 122766 # 122951 # -1 # ID=1_124;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.473	CCI165_S85_contig_8_124	122766	122951	-	Strict	100	109.383	rsmA	85.25	3005069	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCTGATTCTGACTCGTCGAGTTGGTGAGACCCTCATGATTGGAGATGAGGTCACTGTGACAGTTTTAGGGGTGAAGGGTAACCAGGTTCGTATTGGCGTAAACGCCCCTAAAGAAGTATCTGTACACCGTGAAGAGATCTACCAGCGTATTCAGGCTGAAAAATCCCAGCAGTCCAGTTACTAA	MLILTRRVGETLMIGDEVTVTVLGVKGNQVRIGVNAPKEVSVHREEIYQRIQAEKSQQSSY	MLILTRRVGETLMVGDDVTVTVLGVKGNQVRIGVNAPKEVAVHREEIYQRIQKEKDQEPNH	100.00	gnl|BL_ORD_ID|2798|hsp_num:0	3807			0	183	trimethoprim; chloramphenicol
CCI165_S85_contig_12_21 # 20752 # 23100 # -1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.566	CCI165_S85_contig_12_21	20752	23100	-	Strict	1500	1607.04	LptD	98.85	3005059	protein homolog model	n/a	n/a	carbapenem; peptide antibiotic; aminocoumarin antibiotic; rifamycin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGAAAAAACGTATTCCCAGCCTCCTGGCTACGATGATTGCCAGCGCCTTGTATAGCCAACAAGGCCTCGCTGCCGATCTCGCAACGCAATGTATGCTTGGCGTGCCAAGCTTTGATCGTCCGCTCGTGGAAGGGCGGCCTGGCGATCTGCCGGTGACGATTAACGCCGATCATGCGAAGGGCAATTACCCGGACAACGCCGTCTTTACCGGCAACGTCGATATCAACCAGGGGAATAGCCGCCTCCGCGCCGACGAAGTTCAGCTGCATCAGCAGCAGGCCGCGGGCCAGGCGCAGCCGGTGCGCACGGTGGACGCGCTGGGCAACGTGCATTACGACGATAACCAGGTGATCCTCAAAGGACCAAAAGCCTGGTCGAATCTGAATACCAAAGATACCAACGTCTGGCAGGGCGATTATCAGATGGTCGGACGCCAGGGACGCGGTACTGCTGACCTGATGAAACAGCGCGGTGAAAACCGCTATACCATTCTGGAAAACGGCAGCTTTACCTCCTGTCTGCCGGGCTCCGACACCTGGAGCGTCGTGGGCAGCGAAGTTATCCACGATCGCGAAGAGCAGGTCGCCGAGATCTGGAACGCTCGCTTCAAGCTTGGCTCCGTGCCGATTTTCTACAGCCCCTACCTGCAGCTGCCGGTGGGCGATAAGCGTCGTTCAGGCTTCCTGATCCCGAACGCGAAATACAGCACCAAAAACGGCGTGGAATTCTCCCTGCCGTACTACTGGAACATCGCGCCAAACTTCGATGCCACCATCACCCCGCACTATATGAACAAGCGCGGCGGCGTGATGTGGGAAAACGAATTCCGCTACCTGACCCAGCTCGGCAGCGGCTTAACGGAGTTCGACTACCTGCCGTCGGATAAAGTCTACGAAGATGACCACTCCAGCGACAGCAACAGCCGACGCTGGCTGTTCTACTGGAACCACTCCGGGGTTATCGATCAGGTGTGGCGTCTGAACGCTGACTACACCAAGGTCAGCGATCCTGACTACTTCAACGATTTCAGCTCGAAGTATGGTTCCAGTACCGACGGCTATGCGACGCAGAAATTCAGCGCCGGGTATGTCAATCAGAACTTTGACGCCACGGTCTCAACCAAGCAGTTCCAGGTCTTCGATCGGGAGTCGAGCAACTCCTACTCGGCTGAGCCGCAGCTCGACATTAACTACTACCAGAACGATGTCGGTCCGTTCGATACCCATCTGTACGGCCAGGTCGCCCATTTTGTTAACTCGAATAACAACATGCCGGAAGCGACCCGCGTTCACTTCGAACCGACGATCAACCTGCCGCTGTCGAACGGCTGGGGCAGTCTGAATACCGAAGCCAAGCTGCTGGCGACCCACTACCAGCAGAGCAACCTCGATAAGTACAACGCCGCCAACGGCACGGACTACAAAGAATCCGTTAGCCGCGTGATGCCGCAGTTTAAAGTCGACGGCAAAATGGTCTTCGAGCGCGACCTGCAGGAGGGATTCACCCAAACGCTGGAACCGCGCATGCAGTATCTGTATGTGCCGTACCGCGATCAGAGTGAAATCGGCAGCTACGACTCCACGCTGTTGCAGTCGGACTACACCGGCCTGTTCCGCGACCGTACCTATAGCGGTCTCGACCGCATCGCGTCGGCCAATCAGGTCACTACCGGTATCACCTCGCGCGTGTATGACGCCGCCGCGGTGGAACGTTTTAATATTTCCGTTGGTCAAATCTACTATTTCACCGAGTCACGCACCGGTGATGACAACATCAACTGGGAGAACAACGACACCACGGGTTCACTGGTATGGGCCGGCGACACCTACTGGCGCATTGCCGATAACTGGGGTCTGCGCGGCGGGATCCAGTACGATACGCGTCTGGATAACGTCGCAACCGGTAACGGCACCATTGAATACCGTCGCGATGAAAACCGCTTAGTCCAGCTTAACTATCGTTACGCCAGCCCGGAATATATTCAGGCCACACTGCCGTCATATTCCACCGCGGCGCAATATAAAGAGGGTATCTCGCAGGTGGGGATGACCGCCAGCTGGCCGATCGTCGATCGCTGGTCCGTGGTCGGTGCCTACTACTACGATACCAATACCCGGAAAGCAGCAAACCAGATGTTGGGTGTCCAGTATAACTCCTGCTGCTACGCCATCCGTCTTGGCTACGAACGCAAAGTCAACGGCTGGGATAGCAACAACAACGGCGGCGAGAGCAAATACGACAACACCTTCGGAATCAATATCGAATTGCGCGGTCTGAGCTCTAACTACGGCCTCGGCACCCAGCAGATGCTGCGTTCGAACATTTTACCGTACCAGAGCTCCCTGTGA	MKKRIPSLLATMIASALYSQQGLAADLATQCMLGVPSFDRPLVEGRPGDLPVTINADHAKGNYPDNAVFTGNVDINQGNSRLRADEVQLHQQQAAGQAQPVRTVDALGNVHYDDNQVILKGPKAWSNLNTKDTNVWQGDYQMVGRQGRGTADLMKQRGENRYTILENGSFTSCLPGSDTWSVVGSEVIHDREEQVAEIWNARFKLGSVPIFYSPYLQLPVGDKRRSGFLIPNAKYSTKNGVEFSLPYYWNIAPNFDATITPHYMNKRGGVMWENEFRYLTQLGSGLTEFDYLPSDKVYEDDHSSDSNSRRWLFYWNHSGVIDQVWRLNADYTKVSDPDYFNDFSSKYGSSTDGYATQKFSAGYVNQNFDATVSTKQFQVFDRESSNSYSAEPQLDINYYQNDVGPFDTHLYGQVAHFVNSNNNMPEATRVHFEPTINLPLSNGWGSLNTEAKLLATHYQQSNLDKYNAANGTDYKESVSRVMPQFKVDGKMVFERDLQEGFTQTLEPRMQYLYVPYRDQSEIGSYDSTLLQSDYTGLFRDRTYSGLDRIASANQVTTGITSRVYDAAAVERFNISVGQIYYFTESRTGDDNINWENNDTTGSLVWAGDTYWRIADNWGLRGGIQYDTRLDNVATGNGTIEYRRDENRLVQLNYRYASPEYIQATLPSYSTAAQYKEGISQVGMTASWPIVDRWSVVGAYYYDTNTRKAANQMLGVQYNSCCYAIRLGYERKVNGWDSNNNGGESKYDNTFGINIELRGLSSNYGLGTQQMLRSNILPYQSSL	MKKRIPSLLATMIASALYSQQGLAADLATQCMLGVPSYDRPLVEGRPGDLPVTINADHAKGNYPDNAVFTGNVDINQGNSRLRADEVQLHQQQAAGQAQPVRTVDALGNVHYDDNQVILKGPKAWSNLNTKDTNVWQGDYQMVGRQGRGTADLMKQRGENRYTILENGSFTSCLPGSDTWSVVGSEVIHDREEQVAEIWNARFKLGSVPIFYSPYLQLPVGDKRRSGFLIPNAKYSTKNGVEFSLPYYWNIAPNFDATITPHYMNKRGGVMWENEFRYLTQLGSGLTEFDYLPSDKVYEDDHSSDSNSRRWLFYWNHSGVIDQVWRLNADYTKVSDPDYFNDFSSKYGSSTDGYATQKFSAGYVNQNFDATVSTKQFQVFDRESSNSYSAEPQLDVNYYQNDVGPFDTHLYGQVAHFVNSNNNMPEATRVHFEPTINLPLSNGWGSLNTEAKLLATHYQQSNLDKYNAANGTDYKESVSRVMPQFKVDGKMVFERDLQEGFTQTLEPRVQYLYVPYRDQSEIGNYDSTLLQSDYTGLFRDRTYSGLDRIASANQVTTGLTSRVYDAAAVERFNISVGQIYYFTESRTGDDNINWENNDTTGSLVWAGDTYWRIADEWGLRGGIQYDTRLDNVATGNGTIEYRRDENRLVQLNYRYASPEYIQATLPSYSTAAQYKQGISQVGMTASWPIVDRWSVVGAYYYDTNTRKAANQMLGVQYNSCCYAIRLGYERKVNGWNSNDNGGESKYDNTFGINIELRGLSSNYGLGTQQMLRSNILPYQSSL	100.00	gnl|BL_ORD_ID|2790|hsp_num:0	3799			0	2346	novobiocin; rifampin; imipenem; polymyxin B
CCI165_S85_contig_12_51 # 61627 # 62577 # 1 # ID=1_51;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.508	CCI165_S85_contig_12_51	61627	62577	+	Strict	500	535.028	leuO	82.45	3003843	protein homolog model	n/a	n/a	nucleoside antibiotic; disinfecting agents and antiseptics	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGTTAATTGAAAGTCCAGAATATAAATCAGCCCCCGGACAGGAAGTCGTAAAACCTCAACTACGGATGGTTGATCTCAATCTGCTTACCGTTTTTGATGCGGTTATGCAGGAACAGAATATTACCCGTGCCGCCCATACGCTCGGCATGTCTCAACCGGCGGTGAGCAACGCGGTTTCACGTCTGAAAGTGATGTTTAATGATGAACTGTTTGTGCGCTATGGCCGCGGTATTCAGCCGACGGCGCGGGCCTATCAGCTCTTTGGCTCAGTGCGCCAGGCGCTGCAGCTGGTGCAAAACGAATTTCCAGGCTCCGGTTTTGAACCACTGAGCAGTGAGCGTGTTTTCAATCTGTGCGTCTGTAGCCCGCTGGATAACATCCTGACGTCGGTAATTTTTAATAAAGTCGCCGAAATCGCGCCCAATATTCATTTAGTCTTTAAATCAGCGCTTAATCAAAATACGGAACATCAGTTACGTTATCAGGAAACGGAATTTGTGATCGGTTATGAAGAGTTTCGTCGTCCTGAATTTGCCTGTGTACCGCTATTCAAAGATGAAATGGTTCTGGTGGCTAGCCGCAACCATCCGCGTATCTCCGGACCGGTGATGGAGGCTGATATTTATCGCGAGGAGCATGCCGCGGTGGCTCTCGATCGGTATGCCTCATTCAGTCTGCCGTGGTATGACACCGCCGATAAACAAGCGCGCATCGCATATCAAGGTAATGCGATGGTCAGCGTATTAAACGTGGTGTCGCAAACGCAGATGGTGGCCATTGCGCCGCGCTGGCTGGCAAATGAGTTTGCCGATAAGTTAGCGCTGCAAATATTACCTCTGCCGCTGAAGGTGAATAGCCGGACCTGCTATCTCTCCTGGCACGAAGCGGCGGGTCGCGATAAAGGCCATCAGTGGATGGAAGAGCTGCTGGTGGATATTTGTCAGCGCTGA	MLIESPEYKSAPGQEVVKPQLRMVDLNLLTVFDAVMQEQNITRAAHTLGMSQPAVSNAVSRLKVMFNDELFVRYGRGIQPTARAYQLFGSVRQALQLVQNEFPGSGFEPLSSERVFNLCVCSPLDNILTSVIFNKVAEIAPNIHLVFKSALNQNTEHQLRYQETEFVIGYEEFRRPEFACVPLFKDEMVLVASRNHPRISGPVMEADIYREEHAAVALDRYASFSLPWYDTADKQARIAYQGNAMVSVLNVVSQTQMVAIAPRWLANEFADKLALQILPLPLKVNSRTCYLSWHEAAGRDKGHQWMEELLVDICQR	MPEVQTDHPETAELSKPQLRMVDLNLLTVFDAVMQEQNITRAAHALGMSQPAVSNAVARLKVMFNDELFVRYGRGIQPTARAFQLFGSVRQALQLVQNELPGSGFEPASSERVFHLCVCSPLDSILTSQIYNHIEQIAPNIHVMFKSSLNQNTEHQLRYQETEFVISYEDFHRPEFTSVPLFKDEMVLVASKNHPTIKGPLLKHDVYNEQHAAVSLDRFASFSQTWYDTVDKQASIAYQGMAMMSVLSVVSQTHLVAIAPRWLAEEFAESLELQVLPLPLKQNSRTCYLSWHEAAGRDKGHQWMEEQLVSICKR	100.64	gnl|BL_ORD_ID|4917|hsp_num:0	5921			36	942	acriflavine; puromycin
CCI165_S85_contig_22_13 # 10357 # 11748 # -1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.578	CCI165_S85_contig_22_13 	10357	11748	-	Strict	850	863.603	Escherichia coli UhpT with mutation conferring resistance to fosfomycin	95.03	3003890	protein variant model	E350Q	n/a	phosphonic acid antibiotic	antibiotic target alteration	antibiotic-resistant UhpT	ATGCTGGCCTTTCTGAATCAGGTTCGTAAGCCGACCCTGGATCTGCCGCTCGACGTGCGGCGCAAAATGTGGTTCAAACCTTTCATGCAGTCCTATCTGGTGGTCTTCATTGGCTACCTGACCATGTACCTGATCCGCAAGAACTTTAATATTGCGCAGAACGACATGATCTCCACCTACGGGTTGAGCATGACCCAGCTGGGGATTATTGGCCTGGGCTTCTCCATTACCTACGGCGTAGGGAAAACCCTGGTTTCCTACTATGCCGATGGCAAAAACACCAAGCAGTTCCTGCCGTTTATGCTGATCCTCTCCGCCATCTGCATGCTGGGCTTTAGCGCCAGTATGGGTGCGGGTTCCACCAGCCTGTTCCTGATGATCGCCTTCTATGCGCTAAGCGGCTTCTTCCAGAGCACCGGCGGCTCGTGCAGCTATTCCACCATCACCAAATGGACGCCACGACGCAAACGCGGCACCTTCCTCGGCTTCTGGAATATCTCTCACAACCTCGGCGGCGCCGGCGCGGCGGGCGTGGCGCTGTTTGGCGCCAACTATCTGTTCGACGGCCACGTGATCGGCATGTTTATCTTCCCGTCGATTATTGCGCTGATCGTCGGCTTTATTGGCCTGCGCTACGGTAGCGACTCGCCGGAATCCTACGGCCTCGGCACGGCGGAGGAGCTGTTTGGCGAAGCGATCAGCGAAGAGGATAAAGAGACCGAAGAAAACGCGATGACCAAGTGGCAGATCTTTGTTGAGTACGTGCTGAAAAACAAAGTGATCTGGCTGCTGTGCTTCTCCAACATCTTCCTCTACGTGGTGCGTATCGGTATCGATCAATGGTCCACCGTGTACGCCTTCCAGGAGCTGAAGCTGTCGAAAGAGGTGGCGATTCAGGGGTTTACCCTGTTTGAGGTCGGTGCCCTGGTCGGCACGCTGCTGTGGGGCTGGCTGTCGGACCTGGCCAACGGCCGCCGCGCGCTGGTGGCCTGCATCGCGCTGGCGCTGATTATCGCCACTCTCGGCGTTTATCAACATGCCAGCAATCAGTACGTCTATCTGGCTTCGCTGTTTGCGCTGGGCTTCCTGGTGTTTGGCCCGCAGCTGCTGATTGGCGTTGCCGCCGTTGGCTTCGTACCGAAAAAAGCGATCGGCGCCGCCGATGGGATCAAGGGCACTTTCGCCTATCTGATCGGCGATAGCTTCGCCAAGCTGGGCCTCGGGATGATCGCCGACGGCACCCCGGTCTTTGGCCTCACCGGCTGGGCCGGCACCTTTGCGGCGCTGGACGCCGCCGCCATCGGCTGTATCTGCCTGATGGCCATCGTGGCTATCTTCGAAGAGCGTAAAATTCGCCGCGAGAAAAAGAACCGTATTTTGCAGACTGCCTGA	MLAFLNQVRKPTLDLPLDVRRKMWFKPFMQSYLVVFIGYLTMYLIRKNFNIAQNDMISTYGLSMTQLGIIGLGFSITYGVGKTLVSYYADGKNTKQFLPFMLILSAICMLGFSASMGAGSTSLFLMIAFYALSGFFQSTGGSCSYSTITKWTPRRKRGTFLGFWNISHNLGGAGAAGVALFGANYLFDGHVIGMFIFPSIIALIVGFIGLRYGSDSPESYGLGTAEELFGEAISEEDKETEENAMTKWQIFVEYVLKNKVIWLLCFSNIFLYVVRIGIDQWSTVYAFQELKLSKEVAIQGFTLFEVGALVGTLLWGWLSDLANGRRALVACIALALIIATLGVYQHASNQYVYLASLFALGFLVFGPQLLIGVAAVGFVPKKAIGAADGIKGTFAYLIGDSFAKLGLGMIADGTPVFGLTGWAGTFAALDAAAIGCICLMAIVAIFEERKIRREKKNRILQTA	MLAFLNQVRKPTLDLPLEVRRKMWFKPFMQSYLVVFIGYLTMYLIRKNFNIAQNDMISTYGLSMTQLGMIGLGFSITYGVGKTLVSYYADGKNTKQFLPFMLILSAICMLGFSASMGSGSVSLFLMIAFYALSGFFQSTGGSCSYSTITKWTPRRKRGTFLGFWNISHNLGGAGAAGVALFGANYLFDGHVIGMFIFPSIIALIVGFIGLRYGSDSPESYGLGKAEELFGEEISEEDKETESTDMTKWQIFVEYVLKNKVIWLLCFANIFLYVVRIGIDQWSTVYAFQELKLSKAVAIQGFTLFEAGALVGTLLWGWLSDLANGRRGLVACIALALIIATLGVYQHASNEYIYLASLFALGFLVFGPQLLIGVAAVGFVPKKAIGAADGIKGTFAYLIGDSFAKLGLGMIADGTPVFGLTGWAGTFAALDIAAIGCICLMAIVAVMEERKIRREKKIQQLTVA	100.00	gnl|BL_ORD_ID|2127|hsp_num:0	2373			0	1389	fosfomycin
CCI165_S85_contig_4_64 # 62266 # 62916 # -1 # ID=1_64;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.515	CCI165_S85_contig_4_64 	62266	62916	-	Strict	410	440.654	Klebsiella pneumoniae acrR with mutation conferring multidrug antibiotic resistance	98.61	3003373	protein variant model	Y114F, V165I	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic target alteration; antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGCACGAAAAACCAAACAACAGGCACGTGAAACCCGGCAACTGATTCTGGATGTTGCTCTGCGTCTGTTTTCGCAGCAAGGCGTATCATCTACCTCGTTGGCAACAATTGCAAAAGCTGCGGGTGTAACGAGGGGGGCTATCTACTGGCATTTCAAGAATAAATCAGATTTATTCAACGAAATTTGGGAGCTGTCAGACGCCAGTATTAGCGATCTCGAAATTGAGTATCGGGCAAAATTCCCCAACGATCCACTCTCAGTTATCAGGGAGATATTAGTCTATGTTCTTGAAGCGACAGTGACAGAAGAGCGTCGTCGGTTGATGATGGAGATTATCTTCCATAAGTGCGAATTCGTCGGAGAAATGACCGTAGTGCAGCAGGCCCAGCGGCAGCTCTCCCTGGCGAGCTACGAGCGTATCGAGCAAACCTTAAAAGAGTGTATCGCGGCGAAGCTGTTGCCTGCCAATTTACTCACCCGGCGAGCGGCGATTTTAATGCGCAGCTACCTTTCAGGCCTGATGGAGAACTGGCTGTTTGCTCCCGACTCGTTCGACCTGCATGCGGAAGCGCGTGACTACGTCGCCATCCTGCTGGAGATGTATCAATTCTGCCCCACGCTTCGCGGCCCGGAGAGCCTGCCAGCTTAA	MARKTKQQARETRQLILDVALRLFSQQGVSSTSLATIAKAAGVTRGAIYWHFKNKSDLFNEIWELSDASISDLEIEYRAKFPNDPLSVIREILVYVLEATVTEERRRLMMEIIFHKCEFVGEMTVVQQAQRQLSLASYERIEQTLKECIAAKLLPANLLTRRAAILMRSYLSGLMENWLFAPDSFDLHAEARDYVAILLEMYQFCPTLRGPESLPA	MARKTKQQARETRQLILDVALRLFSQQGVSSTSLATIAKAAGVTRGAIYWHFKNKSDLFNEIWELSDASISDLEIEYRAKFPNDPLSVIREILVYVLEATVTEERRRLMMEIIYHKCEFVGEMTVVQQAQRQLSLASYERIEQTLKECIAAKLLPANLLTRRAAVLMRSYLSGLMENWLFAPDSFDLHAEARDYVAILLEMYQFCPTLRGPESLSA	100.00	gnl|BL_ORD_ID|1973|hsp_num:0	1989			0	648	tigecycline; tetracycline; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
CCI165_S85_contig_12_58 # 68796 # 70562 # 1 # ID=1_58;partial=00;start_type=ATG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.568	CCI165_S85_contig_12_58 	68796	70562	+	Strict	500	595.504	Haemophilus influenzae PBP3 conferring resistance to beta-lactam antibiotics	52.2	3004446	protein variant model	D350N, S357N	n/a	cephalosporin; cephamycin; penam	antibiotic target alteration	Penicillin-binding protein mutations conferring resistance to beta-lactam antibiotics	ATGAAAGCAGCGCCAAAAACGCCTAAAGCAAAACGTCAGGAAGAACAGGCCAACTTTATCAGTTGGCGTTTTGCGTTGCTGTGCGGCTGTATTCTACTGGCGCTGGCTTTTCTGCTGGGGCGGGTTGCCTGGCTACAGGTAGTCAGCCCGGACATGCTGGTGCGCCAGGGCGATATGCGTTCTCTGCGCGTACAGGAAGTATCCACCGCGCGCGGGATGATTACCGACCGCTCCGGTCGTCCGCTTGCGGTCAGCGTGCCGGTGAAGGCTATCTGGGCCGATCCAAAAGAACTTCATGATGCCGGCGGGGTAACCCTGGATACGCGCTGGAAGGCGCTGGCGGATGCCCTCAATATGCCGCTGGATCAGCTGGCGACGCGCATCAATACCAATCCGCGGATGCGTTTCATCTATCTGGCGCGTCAGGTTAACCCTGACATGGCCGACTACATCAAAAAACTGAAGCTGCCGGGCATTCATCTACGTGAAGAATCCCGTCGTTACTACCCTTCCGGGGAAGTGACTGCTCACCTCATCGGCTTTACCAACGTCGACAGCCAGGGGATTGAAGGGGTCGAAAAGAGCTTTGATAAATGGCTTACCGGCCAGCCGGGCGAGCGTATCGTGCGTAAAGACCGCTATGGCCGGGTAATTGAAGACATCTCTTCCACCGACAGCCAGGCGGCGCACAACCTGGCGCTGAGCATCGACGAGCGTCTGCAGGCGCTCGTCTATCGTGAGCTGAACAACGCCGTGGCCTTTAACAAAGCCGAGTCCGGCAGCGCGGTGTTAGTGGACGTGAACACCGGCGAAGTGCTGGCGATGGCCAACAGCCCGTCCTACAACCCAAACAACTTTGCCGGCACGGCGAAAGACACCATGCGTAACCGCGCCATCACCGACGTGTTCGAACCGGGTTCGACGGTGAAGCCGATGGTGGTGATGACGGCGCTGCAGCGCGGTATCGTCAACGAAAATACCGTGCTCAATACCGTGCCTTATCGAATTAACGGCCACGAAATTAAAGACGTGGCGCGCTACAGCGAATTGACCCTGACCGGGGTACTACAGAAGTCGAGTAACGTCGGTGTTTCTAAGCTGGCGTTAGCGATGCCGTCCTCAGCGTTAGTAGATACTTACTCACGTTTTGGGCTTGGAAAGGCGACCAATTTGGGGTTGGTCGGAGAACGCAGTGGCTTATATCCTCAAAAACAACGGTGGTCTGACATAGAGAGGGCCACCTTTTCTTTCGGCTACGGGCTAATGGTAACCCCGTTACAGTTAGCGCGAGTCTACGCAACGATTGGCAGCTACGGCATCTATCGCCCGCTGTCGATTACCAAAGTTGATCCACCGGTTCCGGGCGAACGTGTCTTCCCGGAATCACTCGTTCGTACCGTCGTTCATATGATGGAAAGCGTGGCGCTGCCTGGCGGCGGCGGCGTGAAGGCGGCGATCAAAGGCTATCGCATCGCGATTAAAACCGGTACGGCGAAAAAAGTGGGGCCGGATGGCCGCTACATCAACAAATATATTGCTTACACCGCAGGCGTTGCGCCCGCCAGCCATCCGCGCTTTGCGCTGGTGGTGGTGATCAACGACCCGCAGGCAGGTAAATACTACGGTGGCGCCGTTTCCGCGCCGGTGTTCGGTGCCATCATGGGCGGTGTATTGCGCACCATGAACATCGAGCCGGATGCGCTGGCAACGGGCGAAAAAAGTGAATTTGTAATTAATCAAGGCGAGGGAACAGGTGGCAGATCGTAA	MKAAPKTPKAKRQEEQANFISWRFALLCGCILLALAFLLGRVAWLQVVSPDMLVRQGDMRSLRVQEVSTARGMITDRSGRPLAVSVPVKAIWADPKELHDAGGVTLDTRWKALADALNMPLDQLATRINTNPRMRFIYLARQVNPDMADYIKKLKLPGIHLREESRRYYPSGEVTAHLIGFTNVDSQGIEGVEKSFDKWLTGQPGERIVRKDRYGRVIEDISSTDSQAAHNLALSIDERLQALVYRELNNAVAFNKAESGSAVLVDVNTGEVLAMANSPSYNPNNFAGTAKDTMRNRAITDVFEPGSTVKPMVVMTALQRGIVNENTVLNTVPYRINGHEIKDVARYSELTLTGVLQKSSNVGVSKLALAMPSSALVDTYSRFGLGKATNLGLVGERSGLYPQKQRWSDIERATFSFGYGLMVTPLQLARVYATIGSYGIYRPLSITKVDPPVPGERVFPESLVRTVVHMMESVALPGGGGVKAAIKGYRIAIKTGTAKKVGPDGRYINKYIAYTAGVAPASHPRFALVVVINDPQAGKYYGGAVSAPVFGAIMGGVLRTMNIEPDALATGEKSEFVINQGEGTGGRS	MVKFNSSRKSGKSKKTIRKLTAPETVKQNKPQKVFEKCFMRGRYMLSTVLILLGLCALVARAAYVQSINADTLSNEADKRSLRKDEVLSVRGSILDRNGQLLSVSVPMSAIVADPKTMLKENSLADKERIAALAEELGMTENDLVKKIEKNSKSGYLYLARQVELSKANYIRRLKIKGIILETEHRRFYPRVEEAAHVVGYTDIDGNGIEGIEKSFNSLLVGKDGSRTVRKDKRGNIVAHISDEKKYDAQDVTLSIDEKLQSMVYREIKKAVSENNAESGTAVLVDVRTGEVLAMATAPSYNPNNRVGVKSELMRNRAITDTFEPGSTVKPFVVLTALQRGVVKRDEIIDTTSFKLSGKEIVDVAPRAQQTLDEILMNSSNRGVSRLALRMPPSALMETYQNAGLSKPTDLGLIGEQVGILNANRKRWADIERATVAYGYGITATPLQIARAYATLGSFGVYRPLSITKVDPPVIGKRVFSEKITKDIVGILEKVAIKNKRAMVEGYRVGVKTGTARKIENGHYVNKYVAFTAGIAPISDPRYALVVLINDPKAGEYYGGAVSAPVFSNIMGYALRANAIPQDAEAAENTTTKSAKRIVYIGEHKNQKVN	96.39	gnl|BL_ORD_ID|2497|hsp_num:0	2886			63	1758	ceftriaxone; ampicillin; cefaclor; cefotaxime; cefditoren; cefdinir
CCI165_S85_contig_14_65 # 74538 # 74867 # -1 # ID=1_65;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.536	CCI165_S85_contig_14_65	74538	74867	-	Strict	200	200.29	Escherichia coli soxS with mutation conferring antibiotic resistance	89.72	3003511	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; penem; disinfecting agents and antiseptics	antibiotic target alteration; antibiotic efflux; reduced permeability to antibiotic	ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump; General Bacterial Porin with reduced permeability to beta-lactams	ATGTCCCATCAGGATATTATTCAAACACTGATTGAATGGATTGATGAACATATCGATCAACCACTTAACATTGATGTAGTCGCCAGAAAGTCAGGATACTCGAAGTGGTACCTGCAGCGGATGTTCCGCACCGTGATGCATCAGACGCTGGGGGATTATATTCGTCAGCGCCGCCTGCTGCTGGCGGCGGAGGCGTTGCGAACCACCCAGCGGCCGATCTTTGATATCGCTATGGATCTGGGCTATGTCTCGCAGCAAACCTTCTCGCGGGTCTTCCGCCGGGAGTTTGACCGCACCCCCAGCGACTACCGCCATCAGATCTCCGCGTGA	MSHQDIIQTLIEWIDEHIDQPLNIDVVARKSGYSKWYLQRMFRTVMHQTLGDYIRQRRLLLAAEALRTTQRPIFDIAMDLGYVSQQTFSRVFRREFDRTPSDYRHQISA	MSHQKIIQDLIAWIDEHIDQPLNIDVVAKKSGYSKWYLQRMFRTVTHQTLGDYIRQRRLLLAAVELRTTERPIFDIAMDLGYVSQQTFSRVFRRQFDRTPSDYRHRL	101.87	gnl|BL_ORD_ID|1972|hsp_num:0	2066			0	321	tigecycline; ciprofloxacin; tetracycline; rifampin; chloramphenicol; ampicillin; norfloxacin; cefalotin; triclosan; enrofloxacin
CCI165_S85_contig_19_33 # 46737 # 47459 # 1 # ID=1_33;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.614	CCI165_S85_contig_19_33	46737	47459	+	Strict	450	461.84	baeR	93.75	3000828	protein overexpression model	n/a	n/a	aminoglycoside antibiotic; aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACTGAATTGCCTGTAGATGAAAACACCCCGCGCATTCTTATCGTGGAAGATGAACCCAAGCTCGGCCAGCTGCTGATTGATTATCTGCAGGCCGCCGGCTATGCGCCTACGCTGATTAACCATGGCGACAAAGTCCTGCCCTACGTTCGGCAGACTCCGCCGCACCTGATCCTGCTGGATCTGATGCTGCCCGGTACCGACGGCCTGACGCTGTGCCGCGAAATTCGCCGCTTCTCCGACGTTCCGGTGGTGATGGTGACGGCGAAAATCGAAGAGATCGACCGCCTGCTGGGGCTGGAGATTGGCGCCGACGACTATATTTGCAAGCCCTATAGCCCGCGGGAAGTGGTCGCCCGGGTGAAAACCATTCTCCGCCGCTGCAAGCCGCAGCGCGACCTGCAGGCGCTGGACGCGCAGAGTCCGCTGATTGTCGACGAGGGCCGTTTTCAGGCCTCGTGGCGCGACAAGCTGCTGGACCTCACCCCCGCCGAGTTTCGGCTGCTGAAAACTCTCTCCCAGGAGCCGGGGAAGGTCTTCTCCCGCGAACAGTTGCTCAACCATCTGTATGACGACTATCGGGTAGTGACCGACCGCACCATTGACAGCCACATCAAGAACCTGCGGCGCAAGCTGGAGGCGCTGGACGCCGAACAGTCGTTCATCCGCGCCGTGTACGGGGTTGGCTACCGCTGGGAAGCCGACGCCTGTCGGCTGGCGTAG	MTELPVDENTPRILIVEDEPKLGQLLIDYLQAAGYAPTLINHGDKVLPYVRQTPPHLILLDLMLPGTDGLTLCREIRRFSDVPVVMVTAKIEEIDRLLGLEIGADDYICKPYSPREVVARVKTILRRCKPQRDLQALDAQSPLIVDEGRFQASWRDKLLDLTPAEFRLLKTLSQEPGKVFSREQLLNHLYDDYRVVTDRTIDSHIKNLRRKLEALDAEQSFIRAVYGVGYRWEADACRLA	MTELPIDENTPRILIVEDEPKLGQLLIDYLRAASYAPSLISHGDQVLPYVRQTPPDLILLDLMLPGTDGLTLCREIRRFSDVPIVMVTAKIEEIDRLLGLEIGADDYICKPYSPREVVARVKTILRRCKPQRELQVLDAESPLIVDESRFQASWRSKLLDLTPAEFRLLKTLSHEPGKVFSREQLLNHLYDDYRVVTDRTIDSHIKNLRRKLEALDAEQSFIRAVYGVGYRWEADACRIA	100.00	gnl|BL_ORD_ID|1380|hsp_num:0	1337			0	720	neomycin; amikacin; kanamycin A; tobramycin; novobiocin; gentamicin
CCI165_S85_contig_2_280 # 284692 # 285126 # -1 # ID=1_280;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.547	CCI165_S85_contig_2_280	284692	285126	-	Strict	210	252.292	Escherichia coli AcrAB-TolC with MarR mutations conferring resistance to ciprofloxacin and tetracycline	83.33	3003378	protein overexpression model	S3N	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic target alteration; antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAAAAATACCAGCGACCTGTTCAACGAGATGATCCCGCTGGGCCGCTTGATCCAGATGGTTAACCAGAAAAAAGATCGCCTGCTCAACGACTACCTCTCACCCATGGATATTACCGCGACCCAGTTTCGGGTGCTCTGTTCCATTCGTTGCGAGGTATGTATTACCCCCGTTGAGCTGAAAACCGTGCTTTCCGTCGACCCGGGCGCGATGACGCGTATGCTCGACCGCCTGGCGTGTAAAGGCTGGATTGAACGGTTACCCAACCCCGCTGACAAGCGCGGTGTGCTGGTGCAGTTGACGCCAGACGGCGCAGCCCTTTGCGAGCAGTGTCATCAGGTTGTGGGTCAGAAGTTACACCAGGAGTTAACAAAAAATCTGTCGGCGGACGAAGTCGCCATGCTTGAGCAACTCCTCAAGAAGGTCCTGCCGTAA	MKNTSDLFNEMIPLGRLIQMVNQKKDRLLNDYLSPMDITATQFRVLCSIRCEVCITPVELKTVLSVDPGAMTRMLDRLACKGWIERLPNPADKRGVLVQLTPDGAALCEQCHQVVGQKLHQELTKNLSADEVAMLEQLLKKVLP	MKSTSDLFNEIIPLGRLIHMVNQKKDRLLNEYLSPLDITAAQFKVLCSIRCAACITPVELKKVLSVDLGALTRMLDRLVCKGWVERLPNPNDKRGVLVKLTTGGAAICEQCHQLVGQDLHQELTKNLTADEVATLEYLLKKVLP	100.00	gnl|BL_ORD_ID|1981|hsp_num:0	431			0	432	tigecycline; ciprofloxacin; tetracycline; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
